79/23.01.2006 Hotărîre privind aprobarea Cantităţii substanţelor stupefiante, psihotrope şi a plantelor care conţin astfel de substanţe, depistate în circulaţie ilegală
GUVERNUL REPUBLICII MOLDOVA
H O T Ă R Î R E
privind aprobarea Cantităţii substanţelor stupefiante,
psihotrope şi a plantelor care conţin astfel de
substanţe, depistate în circulaţie ilegală
[Denumirea în redacţia Hot.Guv. nr.223 din 26.03.2024, în vigoare 29.03.2024]
nr. 79 din 23.01.2006
(în vigoare 27.01.2006)
Monitorul Oficial al R.Moldova nr.16-19 art.106 din 27.01.2006
* * *
Notă: În titlu şi pe tot parcursul textului, cuvintele "substanţe narcotice" se substituie cu cuvintele "substanţe stupefiante" conform prin Hot.Guv. nr.103 din 27.02.2017, în vigoare 03.03.2017
În scopul reglementării unor probleme ce ţin de contracararea traficului ilicit de substanţe stupefiante, psihotrope şi plante care conţin substanţe stupefiante sau psihotrope, în temeiul alineatelor (4) şi (5) ale articolului 134/1 al Codului penal al Republicii Moldova nr.985-XV din 18 aprilie 2002 (Monitorul Oficial al Republicii Moldova, 2002, nr.128-129, art.1012), Guvernul
HOTĂRĂŞTE:
Se aprobă Cantitatea substanţelor stupefiante, psihotrope şi a plantelor care conţin astfel de substanţe, depistate în circulaţie ilegală (se anexează).
[Partea dispozitivă în redacţia Hot.Guv. nr.223 din 26.03.2024, în vigoare 29.03.2024]
| PRIM-MINISTRU | Vasile TARLEV |
Contrasemnează: |
|
| Ministrul afacerilor interne | Gheorghe Papuc |
| Ministrul sănătăţii şi protecţiei sociale | Ion Ababii |
| Ministrul justiţiei | Victoria Iftodi |
Chişinău, 23 ianuarie 2006. |
|
| Nr.79. |
|
Aprobată prin Hotărîrea Guvernului nr.79 din 23 ianuarie 2006 CANTITATEA substanţelor stupefiante, psihotrope şi a plantelor care conţin astfel de substanţe, depistate în circulaţie ilegală |
|||
| Nr. d/o | Denumirea substanţei, plantei | Cantităţi mici (pînă la cantitatea indicată) | Cantităţi mari (de la – pînă la) |
| 1 | 2 | 3 | 4 |
|
|
|||
| 1. | Acetorfină | 0,00002 g | 0,00002 g – 0,002 g |
| 2. | Acetil-alfa-metilfentanil | 0,00002 g | 0,00002 g – 0,002 g |
| 3. | Alfa-metilfentanil | 0,00002 g | 0,00002 g – 0,002 g |
| 4. | Alfa-metiltiofentanil | 0,00002 g | 0,00002 g – 0,002 g |
| 5. | Beta-hidroxifentanil | 0,00002 g | 0,00002 g – 0,002 g |
| 6. | Beta-hidroxi-3-metilfentanil | 0,00002 g | 0,00002 g – 0,002 g |
|
[Poziţia 7 abrogată prin Hot.Guv. nr.223 din 26.03.2024, în vigoare 29.03.2024] |
|||
| 8. | Coca frunze (foi de coca) | 5,0 g | 5,0 g – 50,0 g |
| 9. | Desomorfină | 0,0001 g | 0,0001 g – 0,001 g |
| 10. | Dronabinol şi izomerii lui | 0,05 g | 0,05 g – 0,5 g |
| 11. | Etorfină | 0,00002 | 0,00002 g – 0,002 g |
| 12. | Efedron ((metcatinon) substanţă preparată artizanal din efedrină, pseudoefedrină sau din preparate care conţin efedrină sau pseudoefedrină) | 3 ml/0,03 g | 3-50 ml/0,03 g – 5,0 g |
| 13. | Heroină | 0,01 g | 0,01 g – 2,5 g |
| 14. | Ketobemidon | 0,1 g | 0,1 g – 1,0 g |
| 15. | LSD, LSD-25 | Un timbru (doză) | 2 – 10 timbre (doze) |
| 16. | - pai de mac (toate părţile diferitelor specii de mac, mărunţite sau întregi, uscate sau umede, cu excepţia seminţelor coapte, colectate prin diverse metode şi care conţin alcaloizi narcoactivi de opiu). | ||
| uscat | 10 g | 10,0 g – 500 g | |
| verde | 70,0 g | 70,0 g – 1000 g | |
| - extract din mac | 0,5 g | 0,5 g – 5 g | |
| 17. | 3-Metilfentanil | 0,00002 g | 0,00002 g – 0,002 g |
| 18. | 3-Metiltiofentanil | 0,00002 g | 0,00002 g – 0,002 g |
| 19. | MPPP | 0,0001 g | 0,0001 g – 0,001 g |
| 20. | Opium (opiu brut) | 0,1 g | 0,1 g – 25 g |
| 21. | Opium acetilat | 0,1 g | 0,1 g – 5 g |
| 22. | Para-fluorofentanil | 0,00002 g | 0,00002 g – 0,002 g |
| 23. | PEPAP | 0,0001 g | 0,0001 g – 0,001 g |
| 24. | Tiofentanil | 0,00002 g | 0,00002 g – 0,002 g |
| 25. | Tetrahidrocannabinol şi izomerii lui | 0,05 g | 0,05 g – 0,5 g |
| 26. | Acetildihidrocodeină | 0,001 g | 0,001 g – 0,01 g |
| 27. | Acetilmetadolum | 0,001 g | 0,001 g – 0,01 g |
| 28. | Alfentanil | 0,00002 g | 0,00002 g – 0,002 g |
| 29. | Allilprodin | 0,001 g | 0,001 g – 0,01 g |
| 30. | Alfacetilmetadolum | 0,001 g | 0,001 g – 0,01 g |
| 31. | Alfameprodinum | 0,001 g | 0,001 g – 0,01 g |
| 32. | Alfametadolum | 0,001 g | 0,001 g – 0,01 g |
| 33. | Alfaprodinum | 0,001 g | 0,001 g – 0,01 g |
| 34. | Anileridinum | 0,0005 g | 0,0005 g – 0,005 g |
| 35. | Benzetidinum | 0,0002 g | 0,0002 g – 0,002 g |
| 36. | Benzilmorfină | 0,001 g | 0,001 g – 0,01 g |
| 37. | Betacetilmetadolum | 0,001 g | 0,001 g – 0,01 g |
| 38. | Betameprodin | 0,001 g | 0,001 g – 0,01 g |
| 39. | Betametadol | 0,001 g | 0,001 g – 0,01 g |
| 40. | Betaprodin | 0,001 g | 0,001 g – 0,01 g |
| 41. | Bezitramid | 0,0005 g | 0,0005 g – 0,005 g |
| 42. | Butorfanol | 0,002 g | 0,002 g – 0,1 g |
| 43. | Clonitazen | 0,00002 g | 0,00002 g – 0,002 g |
| 44. | Cocaină | 0,15 g | 0,15 g – 5 g |
| 45. | Codeină | 0,1 g | 0,1 g – 5 g |
| 46. | Codoxim | 0,001 g | 0,001 g – 0,01 g |
| 47. | Dextramoramid | 0,0005 g | 0,0005 g – 0,005 g |
| 48. | Dextropropoxifen | 0,1 g | 0,1 g – 1,0 g |
| 49. | Diampromid | 0,0001 g | 0,0001 g – 0,001 g |
| 50. | Dietiltiambuten | 0,002 g | 0,002 g – 0,02 g |
| 51. | Difenoxin | 0,0002 g | 0,0002 g – 0,002 g |
| 52. | Dihidrocodeină | 0,016 g | 0,016 g – 0,16 g |
| 53. | Dihidroetorfină | 0,001 g | 0,001 g – 0,01 g |
| 54. | Dihidromorfină | 0,001 g | 0,001 g – 0,01 g |
| 55. | Dimenoxadol | 0,001 g | 0,001 g – 0,01 g |
| 56. | Dimefeptanol | 0,001 g | 0,001 g – 0,01 g |
| 57. | Dimetilambuten | 0,002 g | 0,002 g – 0,02 g |
| 58. | Dioxafetil butirat (butirat de dioxafetil) | 0,001 g | 0,001 g – 0,01 g |
| 59. | Difenoxilat | 0,001 g | 0,001 g – 0,01 g |
| 60. | Dipipanon | 0,001 g | 0,001 g – 0,01 g |
| 61. | Drotebanol | 0,01 g | 0,01 g – 0,1 g |
| 62. | Ecgonină | 0,001 g | 0,001 g – 0,01 g |
| 63. | Estocin | 0,06 g | 0,06 g – 0,6 g |
| 64. | Etaminal de sodiu | 0,2 g | 0,2 g – 2,0 g |
| 65. | Etilmetiltiambuten | 0,002 g | 0,002 g – 0,02 g |
| 66. | Etilmorfină | 0,008 g | 0,008 g – 8,0 g |
| 67. | Etonitazen | 0,00002 g | 0,00002 g – 0,002 g |
| 68. | Extract din nucă vomică | 0,03 g | 0,03 g – 0,3 g |
| 69. | Etoxeridin | 0,001 g | 0,001 g – 0,01 g |
| 70. | Fenadoxon | 0,001 g | 0,001 g – 0,01 g |
| 71. | Fenampromid | 0,0001 g | 0,0001 g – 0,001 g |
| 72. | Fenazocin | 0,003 g | 0,003 g – 0,03 g |
| 73. | Fenamorfan | 0,0005 g | 0,0005 g – 0,05 g |
| 74. | Fenoperidin | 0,0002 g | 0,0002 g – 0,002 g |
| 75. | Fentanil | 0,002 g | 0,002 g – 0,02 g |
| 76. | Folcodină | 0,001 g | 0,001 g – 0,01 g |
| 77. | Furotidin | 0,005 g | 0,005 g – 0,05 g |
| 78. | Hidrocodon | 0,005 g | 0,005 g – 0,05 g |
| 79. | Hidromorfinol | 0,0001 g | 0,0001 g – 0,001 g |
| 80. | Hidromorfon | 0,001 g | 0,001 g – 0,01 g |
| 81. | Hidroxipetidin | 0,001 g | 0,001 g – 0,01 g |
| 82. | Izumetadom | 0,05 g | 0,05 g – 1,0 g |
| 83. | Kat (fol) | 20,0 g | 20,0 g – 200 g |
| 84. | Levometorfan | 0,002 g | 0,002 g – 0,02 g |
| 85. | Levomoramid | 0,0005 g | 0,0005 g – 0,05 g |
| 86. | Levofenaciclomorfan | 0,0005 g | 0,0005 g – 0,05 g |
| 87. | Levorfanol | 0,0005 g | 0,0005 g – 0,05 g |
| 88. | Metazocin | 0,001 g | 0,001 g – 0,01 g |
| 89. | Metadon | 0,05 g | 0,05 g – 1,0 g |
| 90. | Metadon, produs intermediar | 0,05 g | 0,05 g – 1,0 g |
| 91. | Metildezorfin | 0,001 g | 0,001 g – 0,01 g |
| 92. | Metildihidromorfin | 0,001 g | 0,001 g – 0,01 g |
| 93. | Metopon | 0,0002 g | 0,0002 g – 0,002 g |
| 94. | Moramid, produs intermediar | 0,00002 g | 0,00002 g – 0,002 g |
| 95. | Morfilong | 0,01 g | 0,01 g – 0,8 g |
| 96. | Morferidin (Ethyl 1-[2-(morpholin-4-yl)ethyl]-4-phenylpiperidine-4-carboxylate) | 0,00002 g | 0,00002 g – 0,002 g |
| 97. | Morfină | 0,1 g | 0,1 g – 1,0 g |
| 98. | Metobromură de morfină şi alţi derivaţi morfinici cu azot pentavalent, inclusiv N-oximorfină produşi, unul dintre care este N-oxicodeină | 0,0005 g | 0,0005 g – 0,005 g |
| 99. | Morfină-N-oxid | 0,0005 g | 0,0005 g – 0,005 g |
| 100. | Mirofin | 0,0005 g | 0,0005 g – 0,005 g |
| 101. | Nicocodină | 0,0005 g | 0,0005 g – 0,005 g |
| 102. | Nicocodeină | 0,0005 g | 0,0005 g – 0,005 g |
| 103. | Nicodicodin | 0,0005 g | 0,0005 g – 0,005 g |
| 104. | Nicomorfină | 0,0005 g | 0,0005 g – 0,005 g |
| 105. | Noracimetadol | 0,001 g | 0,001 g – 0,01 g |
| 106. | Norcodeină | 0,001 g | 0,001 g – 0,01 g |
| 107. | Norlevorfanol | 0,0005 g | 0,0005 g – 0,005 g |
| 108. | Normetadon | 0,001 g | 0,001 g – 0,01 g |
| 109. | Normorfină | 0,0005 g | 0,0005 g – 0,005 g |
| 110. | Norpipanon | 0,0005 g | 0,0005 g – 0,005 g |
| 111. | Omnopon | 0,03 g | 0,03 g – 3,0 g |
| 112. | Opium* medicinal | 0,5 g | 0,5 g – 5,0 g |
| 113. | Oxicodon | 0,0002 g | 0,0002 g – 0,002 g |
| 114. | Oximorfon | 0,0002 g | 0,0002 g – 0,002 g |
| 115. | Petidină | 0,005 g | 0,005 g – 0,05 g |
| 116. | Petidină, produs intermediar A | 0,005 g | 0,005 g – 0,05 g |
| 117. | Petidină, produs intermediar B | 0,005 g | 0,005 g – 0,05 g |
| 118. | Petidina, produs intermediar C | 0,005 g | 0,005 g – 0,05 g |
| 119. | Piminodin | 0,001 g | 0,001 g – 0,01 g |
| 120. | Piritramid | 0,015 g | 0,015 g – 1,5 g |
| 121. | Proheptazin | 0,003 g | 0,003 g – 0,03 g |
| 122. | Properidin | 0,003 g | 0,003 g – 0,03 g |
| 123. | Propiram | 0,003 g | 0,003 g – 0,03 g |
| 124. | Preparate medicamentoase a căror componenţă include nu mai puţin de 0,015 g codeină | 0,25 g | 0,25 g – 2,5 g |
| 125. | Racemetorfan | 0,002 g | 0,002 g – 0,02 g |
| 126. | Racemoramid | 0,0005 g | 0,0005 g – 0,005 g |
| 127. | Racemorfan | 0,0005 g | 0,0005 g – 0,005 g |
| 128. | Soluţie "Exadol" | 0,05 g | 0,05 g – 0,5 g |
| 129. | Sombrevin | 0,25 g | 0,25 g – 5,0 g |
| 130. | Sufentanil | 0,00001 g | 0,00001 g – 0,001 g |
| 131. | Tebacon | 0,0007 g | 0,0007 g – 0,007 g |
| 132. | Tebaină | 0,03 g | 0,03 g – 3,0 g |
| 133. | Tilidin | 0,05 g | 0,05 g – 5,0 g |
| 134. | Trimeperidin (promedol) | 0,02 g | 0,02 g – 2,0 g |
| 135. | Salvia divinorium (amestec compus din părţile terminale ale plantei, frunze fără tulpina centrală, uscate sau în stare verde de vegetaţie, mărunţite sau întregi, care conţin salvinorin) | ||
| - uscată | 1g | 1g-300g | |
| - verde | 10g | 10g-500g | |
| 136. | Seminţele trandafirului de Havai (seminţele speciei Argyreia nervosa) | ||
| - uscată | 1g | 1g-300g | |
| - verde | 10g | 10g-500g | |
| 137. | Inflorescenţe şi frunze, fără tulpina centrală, uscate sau în stare verde de vegetaţie, mărunţite sau întregi ale speciei Nymphaea caerulea | ||
| - uscată | 1g | 1g-300g | |
| - verde | 10g | 10g-500g | |
| 138. | CP47, 497 = 2-(3 hidroxiciclohexil)-(2-metiloctan-2-il) fenol | 0,01g | 0,01 g – 2,5 g |
| 139. | CP47, 497-C6 = 2-(3-hidroxiciclohexil)-5-(2-metilheptan-2-il) fenol | 0,01 g | 0,01 g – 2,5 g |
| 140. | CP47, 497-C8 = 2-(3-hidroxiciclohexil)-5-(2-metilnonam-2-il) fenol | 0,01 g | 0,01 g – 2,5 g |
| 141. | CP47, 497-C9 = 2-(3-hidroxiciclohexil)-5-(2-metildecan-2-il) fenol | 0,01 g | 0,01 g – 2,5 g |
| 142. | Fluorometcatinona (flefedrona) = 1-(4-fluorofenil)-2-(metilamino) propan-1-ona | 0,01 g | 0,01 g – 2,5 g |
| 143. | JWH-018 = naftalen-1-il-(1-pentilindol-3-il) metanona | 0,01 g | 0,01 g – 2,5 g |
| 144. | 4-metilmetcatinona (mefedrona) = 1-(4-metilfenil)-2-metilaminopropan-1-ona | 0,01 g | 0,01 g – 2,5 g |
| 145. | 4-metoximetcatinona (metedrona) = 1-(4-metoxifenil)-2-(metilamino) propan-1-ona | 0,01 g | 0,01 g – 2,5 g |
| 146. | Bromo-dragonfly = 1-(8-bromobenzodifuran-4-il)- 2-aminopropan | 0,01 g | 0,01g – 2,5 g |
| 147. | Mase vegetale (amestec compus din părţile terminale ale plantelor de diferite specii, flori, frunze fără tulpina centrală, uscate sau umede, mărunţite sau întregi), care conţin: CP47, 497 = 2-(3 hidroxiciclohexil)-(2-metiloctan-2-il) fenol CP47, 497-C6 = 2-(3-hidroxiciclohexil)-5-(2-metilheptan-2-il) fenol CP47, 497-C8 = 2-(3-hidroxiciclohexil)-5-(2-metilnonam-2-il) fenol CP47, 497-C9 = 2-(3-hidroxiciclohexil)-5-(2-metildecan-2-il) fenol JWH-018 = naftalen-1-il-(1-pentilindol-3-il) metanona |
0,5 g | 0,5 g – 25 g |
| 148. | PVP (a-pirrolidinovalerophenone = 2-Pyrrolilidinovalerophenone-phenyl - 2 (pyrrolidin - 1 - y1) pentan - 1 - one | 0,07 g | 0,07 g – 1 g |
| 149. | 4 – MEC (4-metil-N-Etilcatinona, para-metil-N-etilcatinona) = 2 Ethylamino - 1 - (4 - methylphenyl) - 1 - propanone | 0,1 g | 0,1 g – 3 g |
| 150. | Bufedrona (α-metilamino-butirofenona) = 2 - (metilamino) - 1 - (phenylbutan) - 1 - one | 0,1 g | 0,1 g – 3 g |
| 151. | MDPV (Metilenedioxipyrovalerona) = 1 - (3,4 - Metilenedioxiphenil) - 2-pyrrolidinil - pentan - 1 - one) | 0,03 g | 0,03 g – 0,3 g |
| 152. | Metilona (3,4-metilendioxi-N-metilcatinona) = 2 - metilamino - 1 - (3,4 metilendioxifenil) propan - 1 - one | 0,1 g | 0,1 g – 3 g |
| 153. | AKB48 N-(5-fluropentyl) | 0,00002 g | 0,00002 – 0,002 g |
| 154. | 3-Adamantoilindol − [(adamantan-1-il) (1H-indol-3-il) metanonă] şi derivaţii săi | 0,01 g | 0,01 g – 0,01 g |
| 155. | N-(adamantan-1-il)-1-pentyl-1H-indazol-3-carboxamidă şi derivaţii săi | 0,00002 g | 0,00002 – 0,002 g |
| 156. | AMT(alpha-methyltriptamine) şi derivaţii săi | 0,00002 g | 0,00002 – 0,002 g |
| 157. | 3-butanoil-1-methyl indol şi derivaţii săi | 0,002 g | 0,002 – 0,1 g |
| 158. | 2C-C- 2-(4-Chloro-2,5-dimethoxyohenyl) ethanamine – halucinogen | 0,001 g | 0,001 – 0,01 g |
| 159. | Dimetocaine | 0,01 g | 0,01 g |
| 160. | Etcathinone | 0,001 g | 0,001 – 0,01 g |
| 161. | JWH-250 (1-pentyl-3-(2-metoxiphenylacetyl)-indole) | 0,01 g | 0,01 – 2,5 g |
| 162. | JWH-398 (1-pentyl-3-(-4-chloro-1-naphtoyl)indole | 0,01 g | 0,01 – 2,5 g |
| 163. | HU-210(6aR,10aR)-9-(hidroximethyl)-6,6-dimethyl-3-(2-metiloctan-2-il)-6a,7,10,10a-tetrahidro [cromen-1-ol] | 0,00002 g | 0,00002 – 0,002 g |
| 164. | 5-Meo-DALT | 0,0005 g | 0,0005 – 0,002 g |
| 165. | 2-methyl-1-pentyl-1 H-indol-3-il-(1-naftil)-metan şi derivaţii săi | 0,01 g | 0,01 – 2,5 g |
| 166. | 6-methyl-2-[(4-methyl-phenyl)-amino]-4H-3,1-benzoxazin-4-unul | 0,01 g | 0,01 – 2,5 g |
| 167. | Methylendioxypyrovaleron-methylenedioxypyrovalerone (MDPV) – halucinogen | 0,05 g | 0,05 – 5,0 g |
| 168. | nalbufină | 3 ml/0,03 g | 3 – 50 ml/ 0,03 – 5,0 g |
| 169. | AH 7921(3,4dichloro-N-((1-dimethylamino) cyclohexylmethyl) benzamide) | 0,1 g | 0,1 g - 1,0 g |
| 170. | 5- (2-aminopropyl) indole (5-API, 5-IT, PAL-571) | 0,5g | 0,5 g – 2,5 g |
| 171. | Carfentanil(4-((1-oxopropyl)-phenylamino)-(1-(2-phenylethyl)-4-piperidinecarboxylic acid methylesther) | 0,002 g | 0,002 g – 0,02 g |
| 172. | 2C-C (4-chloro-2,5-dimethoxy- phenethylamine) | 0,001 g | 0,001 g – 0,01 g |
| 173. | 2C-I (2,5 dimethoxy-4-iodphenethylamine) | 0,001 g | 0,001 g – 0,01 g |
| 174. | 2C-T-2 (2,5 dimethoxy-4-ethylthio-phenethylamine) | 0,001 g | 0,001 g – 0,01 g |
| 175. | Fenfluramine (N-ethyl-1-((3-triphlormethyl)phenyl) propan-2-amin) | 0,3 g | 0,3 g – 1,5 g |
| 176. | Heliamin (6, 7 dimethoxy-1,2,3,4-tetrahydroizoquinoline) | 0,05 g | 0,05 g – 0,25 g |
| 177. | JWH-073 (Naphthalene-1-il-(1- buthylindol-3-il) methanone) | 0,01 g | 0,01 g – 2,5 g |
| 178. | Methoxetamine şi derivaţii lui | 0,2 g | 0,2 g – 1,0 g |
| 179. | bk-MMBDB (N-methylbutylone) | 0,05 g | 0,05 g – 5,0 g |
| 180. | 25I-NBOMe (2C-I-NBOMe) | 0,3 g | 0,3 g – 1,5 g |
| 181. | a-PHtP (2-Pyrrolidinoheptanophenone) | 0,07 g | 0,07 g – 1,0 g |
| 182. | Seminţele speciei Turbina corymbosa (Riveacorymbosa) | 3,0 g | 3,0 g – 30,0 g |
| 183. | Fenatin (N-(alpha-methylphenethyl) nicotinamide | 0,5 g | 0,5 g – 2,5 g |
| 184. | Prosidol (Propionilphenylethoxyethylpiperidine)-1-(2- ethoxyethyl)-4-phenylpiperidin-4-yl propionate | 0,5 g | 0,5 g – 2,5 g |
| 185. | Remifentanil (methyl-1-(3-methoxy-3-oxopropyl)-4-(N-phenylpropanamido) piperidine-4-carboxylate) | 0,002 g | 0,002 g – 0,01 g |
| 186. | AB-CHMINACA
C20H28N4O2, Sinonim: N-(1-amino 3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl) -1H-indazole-3-carboxamide |
0,01 g | 0,01 - 0,25 g |
| 187. | AB-PINACA-CHM
C20H28N4O2 Sinonim: N-(1-Carbamoyl-2-methylprop-1-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
0,01 g | 0,01 - 0,25 g |
| 188. | AB-PINACA
C18H26N4O2 Sinonim: N-(1-Carbamoyl-2-methylprop-1-yl)-1-pentyl-1H-indazole-3-carboxamide |
0,01 g | 0,01 - 0,25 g |
| 189. | AB-FUBINACA
C20H21FN4O2 Sinonim: N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide |
0,01 g | 0,01 - 0,25 g |
| 190. | 5F-APINACA
5F-AKB48 APINACA 5 – fluoropentyl analog C23H30FN3O; N-((3s,5s,7s) – adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide |
0,01 g | 0,01 - 0,25 g |
| 191. | 5F-AMB
5F-MMB-PINACA 5F-AMB-PINACA C19H26FN3O3; N-[[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl]-L-valine, methyl eter (S)-methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate |
0,01 g | 0,01 - 0,25 g |
| 192. | MDMB-CHMICA
C22H31N3O3; N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl] carbonyl]-3-methyl-L-valine, methyl eter Methyl2-[[1-(cyclohexylmethyl) 1H-indazole-3-carbonyl] amino]-3,3-dimethylbutanoat |
0,01 g | 0,01 - 0,25 g |
| 193. | Mase vegetale ( amestec de prafuri şi/sau plante sau amestecuri de ierburi, diverse părţi de plante de diferite specii, uscate sau umede, mărunţite sau întregi), care conţin:
AB-CHMINACA AB-PINACA-CHM AB-PINACA AB-FUBINACA 5F-APINACA 5F-AKB48 APINACA 5 – fluoropentyl analog 5F-AMB 5F-MMB-PINACA 5F-AMB-PINACA MDMB-CHMICA |
0,01 g | 0,01 - 0,25 g"; |
| 194. | MMB(N)-BZ-F (MMB FUBINACA sau AMB FUBINACA) C21H22FN3O3, Sinonim: Methyl 2-[1-(4-fluorobenzyl)-1H-indazole-3-carboxamido]-3-methylbutanoate sau methyl (2S)-2-{[1-[(4-fluorophenyl) methyl ] indazole-3-carbonyl] amino}-3-methylbutanoate |
0,01 g | 0,01 - 0,25 g |
| 195. | ADB-FUBINACA(MMBA(N)-BZ-F C21H23FN4O2, Sinonim: N-(1-Amino – 3,3-dimethyl – 1 – oxobutan -2-yl) -1-(fluorobenzyl)-1H-indazole – 3 – carboxamide sau N-(1-Carbamoyl-2,2- dimethylprop-1-yl)-1-(4-fluorobenzyl) – 1H-indazole – 3 carboxamide |
0,01 g | 0,01 - 0,25 g |
| 196. | Bk-EBDP C14H19NO3, Sinonim: 1-(benzo[d] [1,3] dioxo 1-5-y1)-2-(rthylamino) pentan – 1 – one |
0,01 g | 0,01 - 0,25 g |
|
[Poziţia 197 abrogată prin Hot.Guv. nr.223 din 26.03.2024, în vigoare 29.03.2024] |
|||
| 198. | AM-678 C24H23NO, Sinonim: Naphthalen-1-yl-(1-pentylindol-3-yl) methanone sau (1-pentyl-1H-indol-3-yl)-1-naphthalenyl-methanone |
0,01 g | 0,01 - 0,25 g |
| 199. | 2-CB C10H14BrNO2, Sinonim: 2-(4-bromo-2,5-dimethoxyphenyl) ethanamine |
0,01 g | 0,01 - 0,25 g |
| 200. | 2-Naphthaleneacetic acid C17H23NO4 , Sinonim: Tert-butoxycarbonylamino(1,2,3,4-tetrahydronaphthalen-2- yl)aceticacid |
0,01 g | 0,01 - 0,25 g |
| 201. | Ethyl ester C6H13N3O2, Sinonim: Ethyl N (aminoiminomethyl)-N-methylglycine |
0,01 g | 0,01 - 0,25 g |
| 202. | 2-Ethylamino-1-(3,4-methylenedioxyphenyl) pentan-1-one C10H13NO2 , Sinonim: bk-PMA |
0,01 g | 0,01 - 0,25 g |
| 203. | (C7)-CP 47 , 497 sau CP 47 , 497/2-[(1S,3R)-3-Hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol | 0,001 g | 0,001 g - 0,1 g |
| 204. | JWH-175 3-[(Naphthalen-1-yl)methyl]-1-pentyl-1H-indole | 0,001 g | 0,001 g - 0,1 g |
| 205. | MDMB-FUBINACA sau MDMB(N)-Bz-F sau FUB-MDMB/Methyl N-{1-[(4-fluorophenyl) methyl]-1H-indazole-3-carbonyl}-3-methyl-L-valinate | 0,001 g | 0,001 g - 0,1 g |
| 206. | Methamphetamine / N-Methyl-1-phenylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 207. | 1-(2,3,4 - Trimethoxybenzyl)-piperazine dihydrocloride / C14H22N2O3 ˇ 2HCl / 1-(2,3,4 - Trimethoxybenzyl)-piperazine dihydrocloride | 0,001 g | 0,001 g - 0,1 g |
| 208. | 1,3 – Dimethylbutylamine / C6H15N / 1,3 – Dimethylbutylamine sau 1,3-DMBA / DMBA / AMP / 4-amino-2-methylpentane | 0,001 g | 0,001 g - 0,1 g |
| 209. | 1-(2,5 - Dimethoxybenzyl)-piperazine / C13H20N2O2 / 1-[(2,5Dimethoxyphenyl)methyl]piperazine / 1-(2,5-Dimethoxybenzyl)piperazine sau 2,5-DMBP / 2,5-DMBZP | 0,001 g | 0,001 g - 0,1 g |
| 210. | 1- Phenylethylamine / C8H11N / 1-phenylethan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 211. | 1-Phenyl-1-propanamine / C9H13N / 2-(1H-indol-3-yl)-N,N-dipropylacetamide / 1-phenylpropan-1-amine sau alpha-Ethylbenzylamine / 1-Phenylpropylamine | 0,001 g | 0,001 g - 0,1 g |
| 212. | 2-(1H-indol-3-yl)-N,N-dipropylacetamide / C16H22N2O / 2-(1H-indol-3-yl)-N,N-dipropylacetamide | 0,001 g | 0,001 g - 0,1 g |
| 213. | Arecoline / C8H13NO2 / Methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 214. | Bentazepam / C17H16N2OS / 1,3,6,7,8,9-hexahydro-5-phenyl-2H-[1]benzotieno[2,3-e]-1,4-diazepin-2-one | 0,001 g | 0,001 g - 0,1 g |
| 215. | 4-CIC / C12H16ClNO • HCl / 1-(4-chlorophenyl)-2-(isopropylamino)propan-1-one hydrochloride 4-chloro-N-Isopropylcathinone / 4-Chloroiprcathinone sau Clipredrone | 0,001 g | 0,001 g - 0,1 g |
| 216. | Cyclohexylmethylindole / C15H19N / 1-(cyclohexylmethyl)-1H-indole | 0,001 g | 0,001 g - 0,1 g |
| 217. | EPPP / C16H23NO2 / 1-Ethyl-4-phenylpiperidin-4-yl propanoate sau 1-Ethyl-4-phenyl-4-propionoxypiperidine | 0,001 g | 0,001 g - 0,1 g |
| 218. | Ergine / C16H17N3O / 6-Methyl-9,10-didehydroergoline-8β-carboxamide sau (8β)-6-Methyl-9,10-didehydroergoline-8-carboxamide / LA-111 sau d-Lysergamide sau LAA | 0,001 g | 0,001 g - 0,1 g |
| 219. | 4F-NPP / C14H20FNO / 1-(4-fluorophenyl)-2-[(propan-2-yl)amino]pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 220. | 4F-PHP / C16H22FNO / 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)hexan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 221. | 4-Hydroxymethcathinone / C10H13NO2 / 1-(4-hydroxy-phenyl)-2-methylamino-propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 222. | MDC / C10H11NO3 / 2-Amino-1-(1,3-benzodioxol-5-yl)propan-1-one sau 3,4-Methylenedioxycathinone / bk-MDA | 0,001 g | 0,001 g - 0,1 g |
| 223. | 4-MeO-PV9 / C19H29NO2 / 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)octan-1-one sau 4-MeO-alpha-POP, 4-MeO-α-PV9 | 0,001 g | 0,001 g - 0,1 g |
| 224. | N-(2,6-Dimethylphenyl)-1- piperidineacetamide / C15H22N2O / N-(2,6-Dimethylphenyl)-1-piperidineacetamide | 0,001 g | 0,001 g - 0,1 g |
| 225. | N-Benzyl-1-phenylethylamine / C15H17N / N-benzyl-1-phenylethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 226. | N Propyl–3,4–methylenedioxycathinone/ Propilone / C13H17NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(propylamino)propan-1-one sau Propyl–3,4–methylenedioxycathinone | 0,001 g | 0,001 g - 0,1 g |
| 227. | Pentylindole / C13H17N / 1-Pentyl-1H-indole | 0,001 g | 0,001 g - 0,1 g |
| 228. | Phenmetetrazine / C13H19NO / 4-ethyl-3-methyl-2-phenylmorpholine | 0,001 g | 0,001 g - 0,1 g |
| 229. | 3-Methylphenmetrazine / C12H17NO / 3-methyl-2-(3-methylphenyl)morpholine sau 3-Methylphenmetrazine, 3-MPM, 3-MPH | 0,001 g | 0,001 g - 0,1 g |
| 230. | Phenmetrazine / C11H15NO / 2-phenyl-3-methylmorpholine sau Oxazimedrine | 0,001 g | 0,001 g - 0,1 g |
| 231. | Isophenmetrazine / C11H15NO / 5-methyl-2-phenylmorpholine | 0,001 g | 0,001 g - 0,1 g |
| 232. | Prolintane / C15H23N / 1-(1-Benzylbutyl)pyrrolidine | 0,001 g | 0,001 g - 0,1 g |
| 233. | RH – 34 / C18H19N3O3 / 3-{2-[(2-methoxybenzyl)amino]ethyl}quinazoline-2,4(1H,3H)-dione | 0,001 g | 0,001 g - 0,1 g |
| 234. | Thiopropamine / C7H11NS / α-methyl-2-thiopheneethanamine sau Thienoamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 235. | 1P-LSD (sugativă, timbru) / C23H29N3O2 / N,N-Diethyl-6-methyl-1-propanoyl-9,10-didehydroergoline-8β-carboxamide sau 1-propionyl-lysergic acid diethylamide | 0,001 g | 0,001 g - 0,1 g |
| 236. | 4-fluoroamphetamine / 4 – FA (pulbere/lichid) / C9H12FN / 1-(4-Fluorophenyl)propan-2-amine sau 4-FMP, PFA para-fluoroamphetamine | 0,001 g 0,02 ml |
0,001 g - 0,1 g 0,02 ml – 2 ml |
| 237. | 3-FEA / 3-Fluoroethamphetamine / C11H16FN / 2-(Furan-3-yl)ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 238. | 5-MeO-MiPT (pulbere) / C15H22N2O / 5-methoxy-N-methyl-N-isopropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 239. | 6-APB ( pulbere/tablete) / C11H13NO / 6-(2-aminopropyl)benzofuran | 0,001 g | 0,001 g - 0,1 g |
| 240. | 5-APB / C11H13NO / 5-(2-Aminopropyl)benzofuran | 0,001 g | 0,001 g - 0,1 g |
| 241. | Acrylfentanyl (pulbere) / C22H26N2O / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide | 0,001 g | 0,001 g - 0,1 g |
| 242. | ADB – CHMINACA / MAB-CHMINACA / C21H30N4O2 / N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 243. | alpha-pyrrolidinohexanophenone / alpha-PHP (pulbere) / C16H23NO / 1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one sau PV-7 | 0,001 g | 0,001 g - 0,1 g |
| 244. | Furanylfentanyl (pulbere, spray, capsule/tablete) / C24H26N2O2 / N-phenylN-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide sau FU-F, 2-furanylfentanyl | 0,001 g 0,02 ml |
0,001 g - 0,1 g 0,02 ml – 2 ml |
| 245. | THF-F / C24H30N2O2 / N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]oxolane-2-carboxamide sau THF-fentanyl, Tetrahydrofuranylfentanyl | 0,001 g | 0,001 g - 0,1 g |
| 246. | GHB/ gamma-hydroxybutyrate (lichid) / C4H8O3 / 4-Hydroxybutanoic acid sau γ-Hydroxybutyric acid | 0,001 g 0,02 ml |
0,001 g - 0,1 g 0,02 ml – 2 ml |
| 247. | Mexedrone (pulbere) / C12H17NO2 / 3-methoxy-2-(methylamino)-1-(4-methylphenyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 248. | NEDPA/ Ephenidine (pulbere) / C16H19N / N-ethyl-1,2-diphenylethan-1-amine sau EPE | 0,001 g | 0,001 g - 0,1 g |
| 249. | THJ-018 (pulbere) / C23H22N2O / 3-(naphthalene-1-carbonyl)-1-pentyl-1H-indazole | 0,001 g | 0,001 g - 0,1 g |
| 250. | 5F-THJ-018 / C22H21FN4O / 1-(5-fluoropentyl)-3-(naphthalene-1-carbonyl)-1H-indazole sau THJ-2201 (AM-2201 indazole analogue) | 0,001 g | 0,001 g - 0,1 g |
| 251. | TH-PVP (cristale) / C19H27NO / 2-(Pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)pentan-1-one sau 3',4'-tetramethylene- a-PVP | 0,001 g | 0,001 g - 0,1 g |
| 252. | alpha-POP / PV9 (pulbere) / C18H27NO / 1-Phenyl-2-(pyrrolidin-1-yl)octan-1-one sau α-Pyrrolidino-octanophenone | 0,001 g | 0,001 g - 0,1 g |
| 253. | Pentylone (pulbere) / C13H17NO3 / β-Keto-Methylbenzodioxolylpentanamine sau βk-Methyl-K, βk-MBDP, methylenedioxypentedrone | 0,001 g | 0,001 g - 0,1 g |
| 254. | Ocfentanyl/ Ocfentanil (pulbere) / C22H27FN2O2 / (4-benzylpiperazin-1-yl)(2-(isopentylamino)pyridin-3-yl)methanone sau 2-fluoro MAF, o-fluoro MAF, 2-fluoro Methoxyacetyl fentanyl | 0,001 g | 0,001 g - 0,1 g |
| 255. | 4-ANPP, ANPP/ Despropionylfentanyl / C19H24N2 / N-phenyl-1-(2-phenylethyl)piperidin-4-amine sau 4-anilino-N-phenethylpiperidine | 0,001 g | 0,001 g - 0,1 g |
| 256. | N-ethylhexedrone/ NEH (pulbere) / C14H21NO / 2-(ethylamino)-1-phenylhexan-1-one sau HEXEN | 0,001 g | 0,001 g - 0,1 g |
| 257. | 2-MeO-diphenidine / MXP (pulbere) / C20H25NO / 1-[1-(2-Methoxyphenyl)-2-phenylethyl]piperidine sau Methoxphenidine, 2-MXD | 0,001 g | 0,001 g - 0,1 g |
| 258. | JWH-210 (pulbere/substanţă solidă) / C26H27NO / (4-Ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 259. | Isopropylphenidate (pulbere) / C16H23NO2 / Propan-2-yl phenyl(piperidin-2-yl)acetate sau IPH, IPPD | 0,001 g | 0,001 g - 0,1 g |
| 260. | Flubromazepam / C15H10BrFN2O / 7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one | 0,001 g | 0,001 g - 0,1 g |
| 261. | Phenyl-2-nitropropene (pulbere) / C9H9NO2 / (2-nitro-1-propen-1-yl)-benzene sau P2NP | 0,001 g | 0,001 g - 0,1 g |
| 262. | N-ethylnorpentedrone / Ethylpentylone (tablete) / C13H19NO / 2-(Ethylamino)-1-phenylpentan-1-one sau N-ethlyaminopentiophenone, Ethylpentylone | 0,001 g | 0,001 g - 0,1 g |
| 263. | N,N-Diethylpentylone / C16H23NO3 / 1-(2H-1,3-Benzodioxol-5-yl)-2-(diethylamino)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 264. | O-PCE / Eticyclidone sau 2-(Ethylamino)-2-phenylcyclohexan-1-one sau 2'-oxo-PCE | 0,001 g | 0,001 g - 0,1 g |
| 265. | diButylone / bk-DMBDB / C13H17NO3 / 1-(2H-1,3-Benzodioxol-5-yl)-2-(dimethylamino)butan-1-one sau Methylbutylone | 0,001 g | 0,001 g - 0,1 g |
| 266. | alpha-PEP/ PV8 (pulbere) / C17H25NO / 1-Phenyl-2-(pyrrolidin-1-yl)heptan-1-one sau α-PHPP | 0,001 g | 0,001 g - 0,1 g |
| 267. | MDPEP / C18H25NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)heptan-1-one sau 3,4-methylenedioxy-PV8 | 0,001 g | 0,001 g - 0,1 g |
| 268. | AMB-CHMICA (pulbere) / C22H30N2O3 / Methyl N-[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]-L-valinate sau MMB-CHMICA | 0,001 g | 0,001 g - 0,1 g |
| 269. | alpha-PiHP (pulbere) / C16H23NO / 4-Methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 270. | 5-MeO-DMT (pulbere) / C13H18N2O / 2-(5-Methoxy-1H-indol-3-yl)-N,N-dimethylethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 271. | 5F-AB-FUPPYCA (pulbere) / C20H26F2N4O2 / N2-[1-(5-Fluoropentyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carbonyl]-L-valinamide sau AZ-037 | 0,001 g | 0,001 g - 0,1 g |
| 272. | 4F-MPH / (pulbere) / C14H18FNO2 / Methyl (4-fluorophenyl)(piperidin-2-yl)acetate sau 4-fluoromethylphenidate | 0,001 g | 0,001 g - 0,1 g |
| 273. | 4F-EPH / 4-fluoroethylphenidate (pulbere) / C15H20FNO2 / Ethyl (4-fluorophenyl)(piperidin-2-yl)acetate | 0,001 g | 0,001 g - 0,1 g |
| 274. | 4-Phenylpiperidine (pulbere) | 0,001 g | 0,001 g - 0,1 g |
| 275. | 4-EMC / 4-Ethylmethcathinone (pulbere) / C12H17NO / 1-(4-Ethylphenyl)-2-(methylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 276. | 4-AcO-DMT (pulbere) / C14H18N2O2 / 4-acetoxy-N,N-dimethyltryptamine sau Psilacetin, O-Acetylpsilocin | 0,001 g | 0,001 g - 0,1 g |
| 277. | 3-MeO-PCP (tablete) / C18H27NO / 1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine sau 3-Methoxyphencyclidine | 0,001 g | 0,001 g - 0,1 g |
| 278. | 3-fluorophenmetrazine/ 3-FPM (pulbere, cristale) / C11H14FNO / 2-(3-fluorophenyl)-3-methylmorpholine sau 3-FPH, PAL-593 | 0,001 g | 0,001 g - 0,1 g |
| 279. | 3,4-dichloromethylphenidate (pulbere) / C14H17Cl2NO2 / Methyl (3,4-dichlorophenyl)(piperidin-2-yl)acetate sau 3,4-DCMP | 0,001 g | 0,001 g - 0,1 g |
| 280. | 2-FA (pulbere) / C9H12FN / 1-(2-Fluorophenyl)propan-2-amine sau 2- fluoroamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 281. | 2C-B-fly (tablete) / C12H14BrNO2 / 2-(8-bromo-2,3,6,7-tetrahydrofuro [2,3-f][1] benzofuran-4-yl)ethanamine | 0,001 g | 0,001 g - 0,1 g |
| 282. | 3C-B-fly / C13H16BrNO2 / 1-(8-bromo-2,3,6,7-tetrahydrobenzo[2,3-f][1]benzofuran-4-yl)-propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 283. | 2C-B (Nexus) (tablete, capsule) / C10H14BrNO2 / 2,5-dimethoxy-4-bromophenethylamine sau BDMPEA | 0,001 g | 0,001 g - 0,1 g |
| 284. | MXE / Methoxetamine (pulbere) / C15H21NO2/ 2-(Ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one sau 3-MeO-2'-oxo-PCE | 0,001 g | 0,001 g - 0,1 g |
| 285. | 3,4-CTMP (pulbere) / C14H17Cl2NO2 / N-methyl-2,3-dihydro-1H-inden-2-amine sau 3,4-dichloromethylphenidate | 0,001 g | 0,001 g - 0,1 g |
| 286. | N-methyl-2AI / NM-2AI / C10H13N / N-methyl-2,3-dihydro-1H-inden-2-amine sau N-methyl-2-aminoindane | 0,001 g | 0,001 g - 0,1 g |
| 287. | 5-IAI / C9H10IN / 5-Iodo-2,3-dihydro-1H-inden-2-amine sau 5-Iodo-2-aminoindane | 0,001 g | 0,001 g - 0,1 g |
| 288. | MDAI / C10H11NO2 / 2H,5H,6H,7H-indeno[5,6-d][1,3]dioxol-6-amine sau 5,6-methylenedioxy-2-aminoindane | 0,001 g | 0,001 g - 0,1 g |
| 289. | MDMAI / C11H13NO2 / N-Methyl-6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine sau 5,6-Methylenedioxy-N-methyl-2-aminoindane | 0,001 g | 0,001 g - 0,1 g |
| 290. | 1-Aminoindane / C9H11N / 2,3-dihydro-1H-inden-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 291. | 2-Aminoindane / 2-AI / C9H11N / 2,3-dihydro-1H-inden-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 292. | MMAI / C11H15NO / 5-Methoxy-6-methyl-2,3-dihydro-1H-inden-2-amine sau 5-Methoxy-6-methyl-2-aminoindane | 0,001 g | 0,001 g - 0,1 g |
| 293. | ETAI / C12H14F3N / N-Ethyl-5-(trifluoromethyl)-2,3-dihydro-1H-inden-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 294. | Methamnetamine / C14H17N/ N-Methyl-1-(naphthalen-2-yl)propan-2-amine sau Methylnaphetamine, MNA, MNT, PAL-1046 | 0,001 g | 0,001 g - 0,1 g |
| 295. | 5-APB NBOMe / C19H21NO2 / 1-(benzofuran-5-yl)-N-(2-methoxybenzyl)propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 296. | 2-EAPB sau 1-(1-Benzofuran-2-yl)-N-ethylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 297. | 2-APB / C11H13NO / 2-(2-aminopropyl)benzofuran | 0,001 g | 0,001 g - 0,1 g |
| 298. | 2-MAPB / C12H15NO / 1-(1-Benzofuran-2-yl)-N-methylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 299. | 6-EAPB / C13H17NO / 1-(benzofuran-6-yl)-N-ethylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 300. | 6-MAPB / C12H15NO / 1-(1-Benzofuran-6-yl)-N-methylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 301. | bk-MPA / C8H11NOS / 2-(Methylamino)-1-(thiophen-2-yl)propan-1-one sau MTP, Thiothinone | 0,001 g | 0,001 g - 0,1 g |
| 302. | 5Cl-bk-MPA / C8H10ClNOS / 1-(5-Chlorothiophen-2-yl)-2-(methylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 303. | 5-EAPB / C13H17NO / 1-(Benzofuran-5-yl)-N-ethylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 304. | alpha-PVT / C13H19NOS / 2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-one sau α-Pyrrolidinopentiothiophenone | 0,001 g | 0,001 g - 0,1 g |
| 305. | 5-APDI / C12H17N / 5-(2-Aminopropyl)-2,3-dihydro-1H-indene sau Indanylaminopropane, IAP | 0,001 g | 0,001 g - 0,1 g |
| 306. | 5-APDB / C11H15NO / 1-(2,3-Dihydro-1-benzofuran-5-yl)propan-2-amine sau 3-Desoxy-MDA, EMA-4 | 0,001 g | 0,001 g - 0,1 g |
| 307. | 6-APDB / C11H15NO / 1-(2,3-Dihydro-1-benzofuran-6-yl)propan-2-amine sau 4-Desoxy-MDA, EMA-3 | 0,001 g | 0,001 g - 0,1 g |
| 308. | Thienoamphetamine/ C7H11NS / 1-(2Thienyl)propan-2-amine, 1-Methyl-2-thiophen-2-yl-ethylamine | 0,001 g | 0,001 g - 0,1 g |
| 309. | 2-Phenyl-3-aminobutane / 2-Phenyl-3-aminobutane, 3-Phenyl-2-butanamine sau β-methylamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 310. | 4-APB / C11H13NO / 1-Benzofuran-4-yl-propan-2-amine sau 4-(2-Aminopropyl)benzofuran | 0,001 g | 0,001 g - 0,1 g |
| 311. | DPIA / C19H25N / 1-Phenyl-N-(1-phenylpropan-2-yl)propan-2-amine sau di-(B-phenylisopropyl)amine | 0,001 g | 0,001 g - 0,1 g |
| 312. | N-formyl-DPIA / C19H23NO / | 0,001 g | 0,001 g - 0,1 g |
| 313. | 3MeO-PCMo / C17H25NO2 / 4-[1-(3-methoxyphenyl)cyclohexyl]morpholine | 0,001 g | 0,001 g - 0,1 g |
| 314. | 3MeO-PCP / 3-Methoxyphencyclidine / C18H27NO / 1-[1-(3-Methoxyphenyl)cyclohexyl]piperidine | 0,001 g | 0,001 g - 0,1 g |
| 315. | Deschloroketamine / DCK / C13H17NO / 2-(Methylamino)-2-phenylcyclohexan-1-one sau DXE, 2'-Oxo-PCM | 0,001 g | 0,001 g - 0,1 g |
| 316. | N-ethylnorketamine / C14H18ClNO / 2-(2-Chlorophenyl)-2-(ethylamino)cyclohexan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 317. | 2-MeO-Ketamine / Methoxyketamine / C14H19NO2 / 2-(2-Methoxyphenyl)-2-(methylamino)cyclohexan-1-one sau 2-MeO-2-deschloroketamine | 0,001 g | 0,001 g - 0,1 g |
| 318. | 4-MeO-PCP / 4-Methoxyphencyclidine / C18H27NO / 1-[1-(4-Methoxyphenyl)cyclohexyl]piperidine sau Methoxydine | 0,001 g | 0,001 g - 0,1 g |
| 319. | 3-MeO-PCE / 3-Methoxyeticyclidine / C15H23NO / N-Ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 320. | Nifoxipam / C15H10FN3O4 / 5-(2-Fluorophenyl)-3-hydroxy-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one | 0,001 g | 0,001 g - 0,1 g |
| 321. | Clonazolam / Clonitrazolam/ C17H12ClN5O2 / | 0,001 g | 0,001 g - 0,1 g |
| 322. | Flubromazolam / C17H12BrFN4 / 8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | 0,001 g | 0,001 g - 0,1 g |
| 323. | Deschloroetizolam / C17H16N4S / 2-Ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine sau Thiénalprazolam | 0,001 g | 0,001 g - 0,1 g |
| 324. | Diclazepam / chlorodiazepam / C16H12Cl2N2O / 7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one sau 2'-chloro-diazepam | 0,001 g | 0,001 g - 0,1 g |
| 325. | Pyrazolam / C16H12BrN5 / 8-Bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | 0,001 g | 0,001 g - 0,1 g |
| 326. | AMB-CHMICA / C22H30N2O3 / Methyl N-[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]-L-valinate sau MMB-CHMICA | 0,001 g | 0,001 g - 0,1 g |
| 327. | MDMB-CHMCZCA / C27H34N2O3 / Methyl N-[9-(cyclohexylmethyl)-9H-carbazole-3-carbonyl]-3-methyl-L-valinate, Methyl (2S)-2-{[9-(cyclohexylmethyl)-9H-carbazole-3-carbonyl]amino}-3,3-dimethylbutanoate | 0,001 g | 0,001 g - 0,1 g |
| 328. | AB-CHMFUPPYCA / C22H29FN4O2 / N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carboxamide sau AB-CHFUPYCA | 0,001 g | 0,001 g - 0,1 g |
| 329. | CBL-018 / C24H23NO2 / Naphthalen-1-yl 1-pentyl-1H-indole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 330. | 5-fluoropentyl-3-pyridinoylindole / C19H19FN2O / [1-(5-Fluoropentyl)-1H-indol-3-yl](phenyl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 331. | 5F-PY-PICA / C18H23FN2O / [1-(5-Fluoropentyl)-1H-indol-3-yl](pyrrolidin-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 332. | FUB-JWH-018 / C26H18FNO / {1-[(4-Fluorophenyl)methyl]-1H-indol-3-yl}(naphthalen-1-yl)methanone sau FUB-018 | 0,001 g | 0,001 g - 0,1 g |
| 333. | 5C-AKB48 / C23H30ClN3O / N-(Adamantan-1-yl)-1-(5-chloropentyl)-1H-indazole-3-carboxamide sau 5Cl-AKB-48 | 0,001 g | 0,001 g - 0,1 g |
| 334. | 5F-EMB-PINACA / C20H28FN3O3 / Ethyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate sau 5F-AEB | 0,001 g | 0,001 g - 0,1 g |
| 335. | 5F-PY-PINACA / C17H22FN3O / [1-(5-Fluoropentyl)-1H-indazol-3-yl](pyrrolidin-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 336. | EMB-FUBINACA / C20H28FN3O3 / Ethyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate sau AEB-FUBINACA, FUB-AEB | 0,001 g | 0,001 g - 0,1 g |
| 337. | MDMB-FUBICA / C23H25FN2O3 / Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indole-3-carbonyl}amino)-3,3-dimethylbutanoate | 0,001 g | 0,001 g - 0,1 g |
| 338. | AMB-CHMINACA / C21H29N3O3 / Methyl (2S)-2-{[1-(cyclohexylmethyl)-1H-indazole-3-carbonyl]amino}-3-methylbutanoate sau MMB-CHMINACA, MA-CHMINACA | 0,001 g | 0,001 g - 0,1 g |
| 339. | SDB-005 / C23H22N2O2 / naphthalen-1-yl 1-pentyl-1H-indazole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 340. | 5F-ADB-PINACA / C19H27FN4O2 / N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 341. | ADB-PINACA / C19H28N4O2 / N-[(2S)-1-Amino-3,3-dimethyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 342. | AB-PINACA N-(2-fluoropentyl) isomer / C18H25FN4O2 / N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(2-fluoropentyl)-1H-indazole-3-carboxamide sau 2-fluoro AB-PINACA | 0,001 g | 0,001 g - 0,1 g |
| 343. | 5Cl-AB-PINACA / C18H25ClN4O2 / 2-{[1-(5-chloropentyl)-1H-indazol-3-yl]formamido}-3-methylbutanamide sau 5Cl-ABP | 0,001 g | 0,001 g - 0,1 g |
| 344. | APP-CHMINACA / C24H28N4O2 / N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide sau PX-3 | 0,001 g | 0,001 g - 0,1 g |
| 345. | APP-FUBINACA / C24H21FN4O2 / N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 346. | MDMB-FUBINACA / C22H24FN3O3 / Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3,3-dimethylbutanoate sau FUB-MDMB, MDMB(N)-Bz-F | 0,001 g | 0,001 g - 0,1 g |
| 347. | CUMYL-5F-P7AICA / C22H26FN3O / (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-7-azaindole- 3-carboxamide) sau SGT-263 | 0,001 g | 0,001 g - 0,1 g |
| 348. | M-CHMIC / C17H21NO2 / methyl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 349. | FUB-144 / C23H24FNO / {1-[(4-Fluorophenyl)methyl]-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl)methanone sau FUB-UR-144 | 0,001 g | 0,001 g - 0,1 g |
| 350. | 5F-MDMB-PINACA / C20H28FN3O3 / Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate sau 5F-ADB, MDMB(N)-2201 | 0,001 g | 0,001 g - 0,1 g |
| 351. | ADAMANTYL-THPINACA / C24H31N3O2 / N-(Adamantan-1-yl)-1-[(oxan-4-yl)methyl]-1H-indazole-3-carboxamide sau ATHPINACA, AD-THPINACA | 0,001 g | 0,001 g - 0,1 g |
| 352. | 5F-AMB-PICA / C20H27FN2O3 / Methyl (2S)-2-{[1-(5-fluoropentyl)-1H-indole-3-carbonyl]amino}-3-methylbutanoate sau MMB-2201, I-AMB | 0,001 g | 0,001 g - 0,1 g |
| 353. | 5F-APP-PINACA / C22H25FN4O2 / N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-(5-fluoropentyl)-1H-indazole-3-carboxamide sau PX-2, FU-PX, PPA(N)-2201 | 0,001 g | 0,001 g - 0,1 g |
| 354. | APP-FUBINACA / C24H21FN4O2 / N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 355. | 5F-APP-PICA / C23H26FN3O2 / N-[(2S)-1-Amino-1-oxo-3-phenylpropan-2-yl]-1-(5-fluoropentyl)-1H-indole-3-carboxamide sau PX-1, SRF-30 | 0,001 g | 0,001 g - 0,1 g |
| 356. | ADB-CHMICA / C22H31N3O2 / N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 357. | CUMYL-5FPINACA / C22H26FN3O / 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 358. | NM-2201 / C24H22FNO2 / Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate sau CBL-2201 | 0,001 g | 0,001 g - 0,1 g |
| 359. | 5F-SDB-005 / C23H21FN2O2 / naphthalen-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 360. | ADB-CHMINACA / C21H30N4O2 / N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide sau N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide sau MAB-CHMINACA | 0,001 g | 0,001 g - 0,1 g |
| 361. | CUMYL-BICA / C22H27N3O / 1-Butyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide sau SGT-24 | 0,001 g | 0,001 g - 0,1 g |
| 362. | CUMYL-PINACA / C22H27N3O / 1-Pentyl-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 363. | 4Cl-CUMYL-PINACA / C22H26ClN3O / N-[2-(4-chlorophenyl)propan-2-yl]-1-pentyl-1H-indazole-3-carboxamide sau SGT-157 | 0,001 g | 0,001 g - 0,1 g |
| 364. | CUMYL-5F-PICA / C23H27FN2O / 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 365. | CUMYL-THPINACA / C23H27N3O2 / 1-[(Oxan-4-yl)methyl]-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide sau SGT-42 | 0,001 g | 0,001 g - 0,1 g |
| 366. | CUMYL-PICA / C23H28N2O / 1-Pentyl-N-(2-phenylpropan-2-yl)-1H-indole-3-carboxamide sau SGT-56 | 0,001 g | 0,001 g - 0,1 g |
| 367. | AB-FUBINACA 2-fluorobenzyl isomer / C20H21FN4O2 / N-[(1S)-1-(aminocarbonyl)-2-methylpropyl]-1-[(2-fluorophenyl)methyl]-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 368. | MN-18 / C23H23N3O / N-(naphthalen-1-yl)-1-pentyl-1H-indazol-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 369. | 5F- MN-18 / C23H22FN3O / 1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 370. | FUB-AKB48 / C25H26FN3O / N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide sau FUB-APINACA, AFUBINACA | 0,001 g | 0,001 g - 0,1 g |
| 371. | 5F-AKB-57 / C23H29FN2O2 / adamantan-1-yl 1-(5-fluoropentyl)-1H-indazole-3-carboxylate sau 5-flouro-APINAC | 0,001 g | 0,001 g - 0,1 g |
| 372. | JWH-071 / C21H17NO / (1-Ethyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 373. | EG-018 / C28H25NO / (Naphthalen-1-yl)(9-pentyl-9H-carbazol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 374. | AM-2201 sau [1-(5-Fluoropentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 375. | FUBIMINA / C23H21FN2O / [1-(5-Fluoropentyl)-1H-benzimidazol-2-yl](naphthalen-1-yl)methanone sau BIM-2201, BZ-2201, FTHJ | 0,001 g | 0,001 g - 0,1 g |
| 376. | 5F-AMBICA / C19H26FN3O3 / N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(5-fluoropentyl)-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 377. | FDU-PB-22 / C26H18FNO2 / Naphthalen-1-yl 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 378. | Mepirapim / C19H27N3O / (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 379. | PB-22 indazole analogue / C22H21N3O2 / 1-pentyl-1H-indazole-3-carboxylic acid, 8-quinolinyl ester sau NPB-22 | 0,001 g | 0,001 g - 0,1 g |
| 380. | 5F- NPB-22 / 5F-QUP7AIC / C22H20FN3O2 / quinolin-8-yl 1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridine-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 381. | M5FPIC / C15H18FNO2 / methyl 1-(5-fluoropentyl)-1H-indole-3-carboxylate sau 5F-PB-22 methylester analogue | 0,001 g | 0,001 g - 0,1 g |
| 382. | N,N-Diethyl-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamine / C21H29N3S/ N-ethyl-N-((2-(1-pentyl-1H-indol-3-yl)thiazol-4-yl)methyl)ethanamine | 0,001 g | 0,001 g - 0,1 g |
| 383. | N-1-Naphthalenyl-1-(5-fluoropentyl)-1H-indazole-3-carboxamide / C23H22FN3O / 1-(5-Fluoropentyl)-N-1-naphthalenyl-1H-indazole-3-carboxamide sau 5F-MN-18 | 0,001 g | 0,001 g - 0,1 g |
| 384. | N-(2-Methoxyethyl)-N-(1-methylethyl)-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamine / C23H33N3OS / N-(2-methoxyethyl)-N-((2-(1-pentyl-1H-indol-3-yl)thiazol-4-yl)methyl)propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 385. | 1-(Cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-1H-benzimidazol-5-carboxamide / C28H37N3O2 / 1-(Cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-1H-benzimidazol-5-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 386. | A-796,260 isomer / C22H30N2O2 / (E)-3,4,4-trimethyl-1-(1-(2-morpholinoethyl)-1H-indol-3-yl)pent-2-en-1-one | 0,001 g | 0,001 g - 0,1 g |
| 387. | SDB-006 / C21H24N2O / N-Benzyl-1-pentyl-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 388. | 5F-SDB-006 / C21H23FN2O / N-Benzyl-1-(5-fluoropentyl)-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 389. | FUB-PB-22 / C25H17FN2O2 / Quinolin-8-yl 1-[(4-fluorophenyl)methyl]-1H-indole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 390. | AM-6527 5-fluoropentyl derivat / C24H23FN2O / (N-5-fluoropentyl) (1-(5-Fluoropentyl)-N-(napthalen-2-yl)-1H-indole-3-carboxamide) sau 5F-NNEI-2 | 0,001 g | 0,001 g - 0,1 g |
| 391. | MN-24 / C24H24N2O / N-(Naphthalen-1-yl)-1-pentyl-1H-indole-3-carboxamide sau NNEI, AM-6527 | 0,001 g | 0,001 g - 0,1 g |
| 392. | AM-2201 indazole / C23H21FN2O / [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone sau THJ-2201, 5-Fluoro-THJ-018 | 0,001 g | 0,001 g - 0,1 g |
| 393. | AM-2201 N-(4-fluoropentyl) / C24H22FNO / (1-(4-fluoropentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 394. | MAM-2201 / C25H24FNO / [1-(5-Fluoropentyl)-1H-indol-3-yl](4-methylnaphthalen-1-yl)methanone sau JWH-122 (5-fluoropentyl), AM-2201 4-methylnaphthyl analog | 0,001 g | 0,001 g - 0,1 g |
| 395. | ADBICA / C20H29N3O2 / N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indole-3-carboxamide sau ADB-PICA | 0,001 g | 0,001 g - 0,1 g |
| 396. | LY2183240-2'-isomer / C17H17N5O / 5-([1,1'-biphenyl]-4-ylmethyl)-N,N-dimethyl-2H-tetrazole-2-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 397. | ADB-PINACA / C19H28N4O2 / N-(1-Amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 398. | 5F-ADB-PINACA / C19H27FN4O2 / N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 399. | 5F-ADBICA / C20H28FN3O2 / N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 400. | AM-1248 Azepane isomer / C26H34N2O / (3,5,7)-adamantan-1-yl(1-(1-methylazepan-3-yl)-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 401. | JWH-412 5-fluoropentyl / C24H21F2NO / (4-fluoro-1-naphthalenyl)[1-(5-fluoropentyl)-1H-indol-3-yl]-methanone sau JWH 412 5-fluoropentyl analog, 5-fluoro JWH 412 | 0,001 g | 0,001 g - 0,1 g |
| 402. | JTE-907 / C24H26N2O6 / N-(Benzo[1,3]dioxol-5-ylmethyl)-7-methoxy-2-oxo-8-pentyloxy-1,2-dihydroquinoline-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 403. | A-836,339 / C16H26N2O2S / N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropane-1-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 404. | JWH-307 bromo derivative / C26H24BrNO / (5-(2-bromophenyl)-1-pentyl-1H-pyrrol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 405. | JWH-030 / C24H22BrNO / Naphthalen-1-yl-(1-pentylpyrrol- 3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 406. | JWH-145 / C26H25NO / 1-Naphthalenyl(1-pentyl-5-phenyl-1H-pyrrol-3-yl)-methanone | 0,001 g | 0,001 g - 0,1 g |
| 407. | UR-144 (N-heptyl analogue) / UR-144 heptyl derivat / C23H33NO / (1-Heptyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 408. | UR-144 / C21H29NO / (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone sau TMCP-018, MN-001 | 0,001 g | 0,001 g - 0,1 g |
| 409. | JWH-368 / C26H24FNO / [5-(3-fluorophenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone | 0,001 g | 0,001 g - 0,1 g |
| 410. | EAM-2201 / C26H26FNO / (1-(5-Fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone sau 5-Fluoro JWH-210, 4'-ethyl-AM-2201 | 0,001 g | 0,001 g - 0,1 g |
| 411. | JWH-methylcyclohexane-8quinolinol / BB-22 / C25H24N2O2 / 8-Quinolinyl 1-(cyclohexylmethyl)-1H-indole-3-carboxylate sau QUCHIC | 0,001 g | 0,001 g - 0,1 g |
| 412. | A-834,735 / C22H29NO2 / 1-(Tetrahydropyran-4-ylmethyl)-1H-indol-3-yl]-(2,2,3,3-tetramethylcyclopropyl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 413. | 5Cl-UR-144 / C21H28ClNO / (1-(5-Chloropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone sau UR-144 N-(5-chloropentyl) | 0,001 g | 0,001 g - 0,1 g |
| 414. | AB-005 / C23H32N2O / 1-[(1-methylpiperidin-2-yl)methyl]-3-(2,2,3,3-tetramethylcyclopropanecarbonyl)-1H-indole | 0,001 g | 0,001 g - 0,1 g |
| 415. | AB-005 azepane isomer / C23H32N2O / 1-(1-methylazepan-2-yl)-3-(2,2,3,3-tetramethylcyclopropanecarbonyl)-1H-indole | 0,001 g | 0,001 g - 0,1 g |
| 416. | 4-HTMPIPO / C21H31NO2 / 4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 417. | JWH-302 / C22H25NO2 / (1-pentyl-3-(3-methoxyphenylacetyl)indole) | 0,001 g | 0,001 g - 0,1 g |
| 418. | JWH 018 N-(5-chloropentyl) derivative / C24H22ClNO / (1-(5-chloropentyl)-1H-indol-3-yl)(naphthalene-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 419. | JWH 018 N-(5-bromopentyl) derivative / C24H22ClNO / [1-(5-bromopentyl)-1H-indol-3-yl](naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 420. | JWH-018 adamantyl carboxamide / APICA / C24H32N2O / N-(Adamantan-1-yl)-1-pentyl-1H-indole-3-carboxamide sau 2NE1, SDB-001 | 0,001 g | 0,001 g - 0,1 g |
| 421. | JWH-018 (cyclohexylmethyl) / C26H25NO / (1-(cyclohexylmethyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 422. | JWH-018 N-(5-hydroxypentyl) / C24H23NO2 / (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 423. | JWH-018 (5-chloropentyl) indazole analogue / C23H21ClN2O / 5Cl-THJ-018 | 0,001 g | 0,001 g - 0,1 g |
| 424. | MAM-2201 chloropentyl derivat / C25H24ClNO / [1-(5-chloropentyl)-1H-indol-3-yl](4-methyl-1-naphthalenyl)-methanone | 0,001 g | 0,001 g - 0,1 g |
| 425. | JWH-122 pentenyl 2-methylindole derivat / C26H25NO / (2-methyl-1-(pent-4-en-1-yl)-1H-indol-3-yl)(4-methylnaphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 426. | JWH-122 (5-Methyl-naphtyl isomer) /C25H25NO / | 0,001 g | 0,001 g - 0,1 g |
| 427. | AM-694 methyl substituent de iod / C21H22FNO / (1-(5-fluoropentyl)-1H-indol-3-yl)(o-tolyl)methanone sau 1-(5-fluoropentyl)-3-(2-methylbenzoyl)indole | 0,001 g | 0,001 g - 0,1 g |
| 428. | AM-694 ethyl substituent de iod / C22H24FNO / 1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-ethylphenyl)methanone sau 1-(5-fluoropentyl)-3-(2-ethylbenzoyl)indole | 0,001 g | 0,001 g - 0,1 g |
| 429. | UR-144 (-2H) sau 1-pentyl-3-(2,2,3,3-tetramethylcyclopropanecarbonyl)-1H-indole sau KM X-1, TMCP-018, MN-001 | 0,001 g | 0,001 g - 0,1 g |
| 430. | STS-135 / C24H31FN2O / N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide sau 5F-APICA | 0,001 g | 0,001 g - 0,1 g |
| 431. | JWH-370 / C27H27NO / [5-(2-Methylphenyl)-1-pentyl-1H-pyrrol-3-yl]-1-naphthalenyl-methanone | 0,001 g | 0,001 g - 0,1 g |
| 432. | 3-(p-Methoxybenzoyl)-N-methylindole | 0,001 g | 0,001 g - 0,1 g |
| 433. | URB-754 / C16H14N2O2 / 6-methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one | 0,001 g | 0,001 g - 0,1 g |
| 434. | HU-331 / C21H28O3 / 3-hydroxy-2-[(1R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylcyclohexa-2,5-diene-1,4-dione | 0,001 g | 0,001 g - 0,1 g |
| 435. | AM-679 / C20H20INO / 2-iodophenyl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 436. | WIN 55212-2 / C27H26N2O3 / (R)-(+)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl( naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 437. | AM-2232 / C24H20N2O / 5-[3-(1-naphthoyl)-1H-indol-1-yl]pentanenitrile | 0,001 g | 0,001 g - 0,1 g |
| 438. | AM-694 chloro derivat / C20H19ClINO / 1-(5-chloropentyl)-1H-indol-3-yl(2-iodophenyl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 439. | JWH-022 / C24H21NO / naphthalen-1-yl[1-(pent-4-en-1-yl)-1H-indol-3-yl]methanone | 0,001 g | 0,001 g - 0,1 g |
| 440. | JWH-387 / C24H22BrNO / 4-bromonaphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 441. | JWH-412 / C24H22FNO / 4-fluoronaphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 442. | JWH-071 / C21H17NO / (1-ethyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 443. | JWH-073 / C23H21NO / (1-butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 444. | JWH-081 / C25H25NO2 / JWH-081(4-Methoxy-1-naphthalenyl)(1-pentyl-1H-indol-3-yl)-methanone | 0,001 g | 0,001 g - 0,1 g |
| 445. | AM-2233 / C22H23IN2O / 2-iodophenyl[1-[(1-methylpiperidin-2-yl)methyl]indol-3-yl]methanone | 0,001 g | 0,001 g - 0,1 g |
| 446. | Org 27569 / C24H28CIN3O / 5-Chloro-3-ethyl-1H-indole-2-carboxylic acid [2-(4-piperidin-1-yl-phenyl)-ethyl]-amide | 0,001 g | 0,001 g - 0,1 g |
| 447. | Org 27759 / C21H24FN3O / N-{2-[4-(dimethylamino)phenyl]ethyl}-3-ethyl-5-fluoro-1H-indole-2-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 448. | Org 29647 / C22H24CIN3O / N-(1-benzylpyrrolidin-3-yl)-5-chloro-3-ethyl-1H-indole-2-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 449. | RCS-4-C4 homolog/ RSC-4 (C4) / C20H21NO2 / 1-butyl-1H-indol-3-yl(4-methoxyphenyl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 450. | RCS-4 / C21H23NO2 / 4-methoxyphenyl(1-pentyl-1H-indol-3-yl)methanone sau SR-19, BTM-4, E-4 | 0,001 g | 0,001 g - 0,1 g |
| 451. | AM-1220 / C26H26N2O / 1-[(1-methylpiperidin-2-yl)methyl]-1H-indol-3-yl (naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 452. | AM-1220 azepane isomer / C26H26N2O / 1-(1-methylazepan-3-yl)-1H-indol-3-yl(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 453. | JWH-007 / C25H25NO / 2-methyl-1-pentyl-1H-indol-3-yl(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 454. | WIN 48,098 / Pravadoline / C23H26N2O3 / (4-Methoxyphenyl)[(2-methyl)-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl]-methanone sau WIN 48098-6 | 0,001 g | 0,001 g - 0,1 g |
| 455. | RCS-4 ortho isomer / C21H23NO2 / 2-methoxyphenyl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 456. | JWH-018 adamantyl derivat / AB-001 / C24H31NO / adamantan-1-yl(1-pentyl-1H-indol-3-yl)methanone sau 1-pentyl-3-(1-adamantoyl)indole JWH-018 adamantoyl derivat | 0,001 g | 0,001 g - 0,1 g |
| 457. | JWH-251 / C22H25NO / 2-(2-methylphenyl)-1-(1-pentylindol-3-yl)ethenone sau 1-pentyl-3-(2-methylphenylacetyl)indole | 0,001 g | 0,001 g - 0,1 g |
| 458. | Methanandamide / C23H39NO2 / N-(1-hydroxypropan-2-yl)icosa-5,8,11,14-tetraenamide sau AM-356 | 0,001 g | 0,001 g - 0,1 g |
| 459. | JWH-182 / C27H29NO / 1-pentylindol-3-yl(4-propylnaphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 460. | CRA-13 / C26H24O2 / naphthalen-1-yl(4-pentoxynaphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 461. | 3-(4-hydroxymethylbenzoyl)-1-pentylindole / C21H23NO2 / 4-(hydroxymethyl)phenyl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 462. | JWH-203 / C21H22CINO / 2-(2-chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethenone | 0,001 g | 0,001 g - 0,1 g |
| 463. | JWH-019 / C25H25NO / 1-hexyl-1H-indol-3-yl(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 464. | JWH-015 / C23H21NO / 2-methyl-1-propyl-1H-indol-3-yl(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 465. | JWH-081 / C25H25NO2 / 4-methoxynaphthalen-1-yl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 466. | RCS-4 / C21H23NO2 / 4-methoxyphenyl(1-pentyl-1H-indol-3-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 467. | JWH-200 / C25H24N2O2 / 1-(2-morpholin-4-ylethyl)indol-3-yl(naphthalen-1-yl)methanone | 0,001 g | 0,001 g - 0,1 g |
| 468. | 4-Cl-alpha-PVP / C15H20ClNO / 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one sau 4-chloro-α-pyrrolidinovalerophenone, 4-chloro-alpha-pyrrolidinopentiophenone | 0,001 g | 0,001 g - 0,1 g |
| 469. | 4-F-alpha-PHP / C16H22FNO / 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)hexan-1-one sau 4'-fluoro-α-Pyrrolidinohexanophenone, 4-fluoro-PHP | 0,001 g | 0,001 g - 0,1 g |
| 470. | bk-IBP / bk-EABDI / C15H21NO / 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)butan-1-one sau NEB-Inden-Analog | 0,001 g | 0,001 g - 0,1 g |
| 471. | 2-MEC / C12H17NO / 2-(ethylamino)-1-(o-tolyl)propan-1-one sau 2-Methylethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 472. | 5-PPDi / C17H23NO / 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 473. | Propylcathinone / N-Propylcathinone / C12H17NO / 1-phenyl-2-(propylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 474. | 2,4-DMMC / C12H17NO / 1-(2,4-dimethylphenyl)-2-(methylamino)propan-1-one sau 2,4-Dimethylmethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 475. | 3,4-DMMC / C12H17NO / 1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one sau 3,4-Dimethylmethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 476. | 2,4-DMEC / C13H19NO / 1-(2,4-dimethylphenyl)-2-(ethylamino)propan-1-one sau 2,4-Dimethylethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 477. | 4-chloro-N,N-dimethylcathinone / 4-CDC / C10H12ClNO / 1-(4-chlorophenyl)-2-(dimethylamino)propan-1-one sau 4-Chloromethcathinone, Clephedrone, 4-CDMD | 0,001 g | 0,001 g - 0,1 g |
| 478. | N,N-Dimethylcathinone / C11H15NO / 2-(Dimethylamino)-1-phenylpropan-1-one sau Metamfepramone, Dimethylcathinone | 0,001 g | 0,001 g - 0,1 g |
| 479. | Nor-mephedrone / 4-Mc / C10H13NO / 2-amino-1-(p-tolyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 480. | 4-ethylethcathinone / 4-EEC / C13H19NO / 2-(ethylamino)-1-(4-ethylphenyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 481. | 4-MeO-alpha-PV9 / C19H29NO2 / 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)octan-1-one sau 4-methoxy α-POP, para-methoxy PV9 | 0,001 g | 0,001 g - 0,1 g |
| 482. | 3,4-DMeO-alpha-PHP / 3,4-dimethoxy-alpha-PHP/ C18H27NO3 / 1-(3,4-dimethoxyphenyl)-2-(pyrrolidin-1-yl)hexan-1-one sau 2,4-DMeO-PHP | 0,001 g | 0,001 g - 0,1 g |
| 483. | 5-BPDi / C19H27NO / 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 484. | alpha-pyrrolidinononaphenone / alpha-PNP / C19H29NO / 1-phenyl-2-pyrrolidin-1-ylnonan-1-one sau Nonanophenone | 0,001 g | 0,001 g - 0,1 g |
| 485. | 4Br-alpha-PVP / C15H20BrNO / 1-(4-Bromophenyl)-2-(1-pyrrolidinyl)-1-pentanone sau 4'-Bromo-α-Pyrrolidinopentiophenone, 4-bromo-α-pyrrolidinvalerophenone | 0,001 g | 0,001 g - 0,1 g |
| 486. | 4-fluoroethcathinone (4-FEC) / C11H14FNO / 2-(ethylamine)-1-(4-fluorphenyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 487. | 1-(2,3-dihydro-1H-inden-5-yl)-2-phenyl-2-(pyrrolidinyl-1-yl) ethan-1-one / C21H23NO / 1-(2,3-dihydro-1H-inden-5-yl)-2-phenyl-2-(pyrrolidinyl-1-yl)ethan-1-one sau Indapyrophenidone | 0,001 g | 0,001 g - 0,1 g |
| 488. | 5-DBFPV / C17H23NO2 / 1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one sau 5-dihydrobenzofuranpyrovalerone | 0,001 g | 0,001 g - 0,1 g |
| 489. | 4F-PBP / C14H18FNO / 1-(4-fluorophenyl)-2-(1-pyrrolidinyl)-1-butanone | 0,001 g | 0,001 g - 0,1 g |
| 490. | bk-IVP / C16H23NO / 1-(2,3-dihydro-1H-inden-5-yl)-2-(ethylamino)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 491. | N-methyl-bk-MMDA-2 / C12H15NO4 / 1-(6-methoxy-1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 492. | MMDA 2-methoxy analog / C11H15NO3 / 6-methoxy-α-methyl-1,3-benzodioxole-5-ethanamine | 0,001 g | 0,001 g - 0,1 g |
| 493. | Methyl-MMDA-2 / C12H17NO3 / 1-(6-Methoxy-2H-1,3-benzodioxol-5-yl)-N-methylpropan-2-amine sau 6-methoxy-MDMA, 2-Methoxy-N-methyl-4,5-methylenedioxyamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 494. | MDPHP / 3,4-MDPHP / C17H23NO3 / 1-(2H-1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 495. | 4-MeO-alpha-PEP / 4-MeO-alpha-PV8 / C18H27NO2 / 1-(4-Methoxyphenyl)-2-(pyrrolidin-1-yl)heptan-1-one sau 4-MeO-α-PHPP | 0,001 g | 0,001 g - 0,1 g |
| 496. | 4F-alpha-POP / 4F-PV9 / C18H26FNO / 1-(4-Methoxyphenyl)-2-(pyrrolidin-1-yl)heptan-1-one sau 4-Fluoro-PV-9, FPOP, 4-Fluoro-α-POP | 0,001 g | 0,001 g - 0,1 g |
| 497. | 3-CMC / C10H12ClNO / 1-(3-chlorophenyl)-2-(methylamino)propan-1-one sau 3-chloromethcathinone, Clophedrone | 0,001 g | 0,001 g - 0,1 g |
| 498. | 4-methyl-N,N-diethylcathinone / 4-MDEC / C14H21NO / 2-(diethylamino)-1-(4-methylphenyl)propan-1-one sau N,N-DEMC, 4-MEC ET | 0,001 g | 0,001 g - 0,1 g |
| 499. | 4-MeO-alpha-PBP / 4-MeOPBP / C15H21NO2 / 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)butan-1-one sau 4-methoxy-α-Pyrrolidinobutiophenone | 0,001 g | 0,001 g - 0,1 g |
| 500. | alpha-PBT / C12H17NOS / 2-(Pyrrolidin-1-yl)-1-(thiophen-2-yl)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 501. | 4F-alpha-PEP / 4F-PV8 / C17H24FNO / 1-(4-Fluorophenyl)-2-(pyrrolidin-1-yl)heptan-1-one sau 4F-α-PHPP | 0,001 g | 0,001 g - 0,1 g |
| 502. | 4-Methyl-N,N-dimethylcathinone / C12H17NO / 2-(dimethylamino)-1-(4-methylphenyl)-1-propanonem sau 4-methyl-N,N-DMC | 0,001 g | 0,001 g - 0,1 g |
| 503. | 4-methoxy-N,N-Dimethylcathinone / C12H17NO2 / 2-(dimethylamino)-1-(4-methoxyphenyl)-1-propanone sau N-Methylmethedrone | 0,001 g | 0,001 g - 0,1 g |
| 504. | 3-MEC sau 2-(Ethylamino)-1-(3-methylphenyl)propan-1-one sau 3-Methylethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 505. | 4-methylpentedrone / 4-MPD / C13H19NO / 2-(methylamino)-1-(4-methylphenyl)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 506. | Dipentylone / C14H19NO3 / 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 507. | 4-Fluoropentedrone / 4-FPD / C12H16FNO / 1-(4-fluorophenyl)-2-(methylamino)pentan-1-one sau 4-fluoro-α-methylamino-Valerophenone | 0,001 g | 0,001 g - 0,1 g |
| 508. | 2-methylmethcathinone (2-MMC) / C11H16ClNO / 2-(methylamino)-1-(2-methylphenyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 509. | DL-4662 / C15H23NO3 / -(3,4-Dimethoxyphenyl)-2-(ethylamino)pentan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 510. | 1-(4-fluorophenyl)-2-(piperidin-1-yl)pentan-1-one sau 1-(4-fluorophenyl)-2-(piperidin-1-yl)pentan-1-one sau 4-Fluoro-α-PVP piperidine analog | 0,001 g | 0,001 g - 0,1 g |
| 511. | 4-Fluoro-α-PVP / C15H20FNO / 1-(4-fluorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one sau 4F-PVP, 4-fluoro-α-pyrrolidinovalerophenone | 0,001 g | 0,001 g - 0,1 g |
| 512. | N-ethylnorpentedrone / C13H19NO / 1-phenyl-2-(ethylamino)pentan-1-one sau α-ethylaminopentiophenone, N-Ethylpentylone, NEP | 0,001 g | 0,001 g - 0,1 g |
| 513. | Hexedrone / ß-propylmethcathinone / C13H19NO / 2-(Methylamino)-1-phenylhexan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 514. | Butylhexedrone / C16H25NO / 2-(butylamino)-1-phenylhexan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 515. | 4'-chloro-alpha-PPP / C13H16ClNO / 1-(4-chlorophenyl)-2-pyrrolidin-1-ylpropan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 516. | 4-fluoro-N-isopropylnorpentedrone / 4F-IPV / C14H20FNO / 1-(4-Fluorophenyl)-2-(isopropylamino)pentan-1-one sau 4-Fluoro-N-isopropylpentedrone | 0,001 g | 0,001 g - 0,1 g |
| 517. | 3-methoxymethcathinone / 3-MeOMC / C11H15NO2 / 1-(3-methoxyphenyl)-2-(methylamino)propan-1-one sau 3-MOMC | 0,001 g | 0,001 g - 0,1 g |
| 518. | 4F-alpha-PVP / C15H20FNO / 1-(4-fluorophenyl)-2-(1-pyrrolidinyl)-1-pentanone sau 4F-α-PVP | 0,001 g | 0,001 g - 0,1 g |
| 519. | 3,4-DMeO-alpha-PVP / C17H25NO3 / 1-(3,4-Dimethoxyphenyl)-2-(1-pyrrolidinyl)-1-pentanone sau 3',4'-Dimethoxy-α-Pyrrolidinopentiophenone | 0,001 g | 0,001 g - 0,1 g |
| 520. | 4-BEC / C11H14BrNO / 1-(4-Bromophenyl)-2-(ethylamino)-1-propanone | 0,001 g | 0,001 g - 0,1 g |
| 521. | 3,4-Dimethylethcathinone (3,4-DMEC) / C13H19NO / 1-(3,4-Dimethylphenyl)-2-(ethylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 522. | 4-Methyl-N-ethylnorpentedrone / C14H21NO / 2-(ethylamino)-1-(4-methylphenyl)pentan-1-one sau 4-MEAP | 0,001 g | 0,001 g - 0,1 g |
| 523. | bk-2C-B / C10H12BrNO3 / 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 524. | 2-FMC / 2-Fluoromethcathinone / C10H12FNO / 1-(2-fluorophenyl)-2-(methylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 525. | bk-PBDB / C14H19NO3 / 1-(1,3-benzodioxol-5-yl)-2-(propylamino)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 526. | 4-methylbuphedrone, N-benzyl derivative / C18H21NO / 2-(benzylamino)-1-(4-methylphenyl)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 527. | 4-MeO-alpha-PVP / C16H23NO2 / 1-(4-methoxyphenyl)-2-(pyrrolidin-1-yl)pentan-1-one sau 4-Methoxy-a-PVP, 4-Methoxy-a-Pyrrolidinopentiophenone | 0,001 g | 0,001 g - 0,1 g |
| 528. | 4-Fluorocathinone / C9H10FNO / 2-amino-1-(4-fluorophenyl)propan-1-one sau 4-FC | 0,001 g | 0,001 g - 0,1 g |
| 529. | 2,4,5-Trimethylmethcathinone / 2,4,5-TMMC / C13H19NO / 2-(methylamino)-1-(2,4,5-trimethylphenyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 530. | 1-phenyl-2-(piperidin-1-yl)butan-1-one / C15H21NO / 1-phenyl-2-(piperidin-1-yl)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 531. | alpha-Pyrrolidinobutyrophenone / alpha-PBP / C14H19NO / 1-Phenyl-2-(1-pyrrolidinyl)-1-butanone | 0,001 g | 0,001 g - 0,1 g |
| 532. | 4-Methylbuphedrone / 4-Me-MABP / C12H17NO / 2-(methylamino)-1-(4-methylphenyl)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 533. | Dimethylone / bk-MDDMA / C12H15NO3 / 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 534. | Brephedrone / 4-BMC /C10H12BrNO / 1-(4-bromophenyl)-2-(methylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 535. | 4-Ethylmethcathinone / 4-EMC / C12H17NO / 1-(4-ethylphenyl)-2-(methylamino)propan-1-one sau 4-Ethylphedrone | 0,001 g | 0,001 g - 0,1 g |
| 536. | N-ethylbuphedrone / C12H17NO / 2-(ethylamino)-1-phenylbutan-1-one sau NEB | 0,001 g | 0,001 g - 0,1 g |
| 537. | 2-Benzylamino-1-(3,4-methylenedioxyphenyl)propan-1-one / BMDP / C17H17NO3 / 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 538. | 2-Benzylamino-1-(3,4-methylenedioxyphenyl)butan-1-one / BMDB / C18H19NO3 / 1-(1,3-benzodioxol-5-yl)-2-(benzylamino)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 539. | 3,4-dimethylmethcathinone / 3,4-DMMC / C12H17NO / 1-(3,4-dimethylphenyl)-2-(methylamino)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 540. | Benzedrone / 4-MBC / C17H19NO / 2-(benzylamino)-1-(4-methylphenyl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 541. | 1-naphyrone / C19H23NO / 1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one sau α-Naphyrone | 0,001 g | 0,001 g - 0,1 g |
| 542. | Pentylone / C13H17NO3 / 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-one sau bk-MDBP | 0,001 g | 0,001 g - 0,1 g |
| 543. | Pentedrone / ß-ethyl-methcathinone / C12H17NO / 1-(methylamino)-1-phenylpentan-2-one, 1-phenyl-2-(methylamino)pentan-1-one sau α-methylamino-valerophenone | 0,001 g | 0,001 g - 0,1 g |
| 544. | 3',4'- Methylenedioxy-alpha-methylPPP /MDMPP / C15H19NO3/ 1-(2H-1,3-Benzodioxol-5-yl)-2-methyl-2-(pyrrolidin-1-yl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 545. | Buphedrone / C11H15NO / 2-(methylamino)-1-phenylbutan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 546. | 4-Fluorobuphedrone/ C11H14FNO / 1-(4-fluorophenyl)-2-(methylamino)butan-1-one sau 4-FBP, 4-F-MABP | 0,001 g | 0,001 g - 0,1 g |
| 547. | 4Cl-Buphedrone / C11H14ClNO / 1-(4-chlorophenyl)-2-(methylamino)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 548. | 4'-Methyl-alpha-pyrrolidinobutyrophenone / MPBP / C15H21NO / 1-(4-methylphenyl)-2-(pyrrolidin-1-yl)butan-1-one sau F 1938 | 0,001 g | 0,001 g - 0,1 g |
| 549. | 3',4'-Methylenedioxy-alpha-pyrrolidinobutyrophenone / MDPBP / C15H19NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 550. | Naphyrone / C19H23NO / (RS)-1-naphthalen-2-yl-2-pyrrolidin-1-ylpentan-1-one sau Naphthylpyrovalerone | 0,001 g | 0,001 g - 0,1 g |
| 551. | Metamfepramone / C11H15NO / 2-dimethylamino-1-phenylpropan-1-one sau 2-(dimethylamino)propiophenone, N,N-Dimethylcathinone, Dimethylpropione, Dimepropione | 0,001 g | 0,001 g - 0,1 g |
| 552. | Methedrone / bk-PMMA / C11H15NO2 / 1-(4-methoxyphenyl)-2-(methylamino)propan-1-one sau para-Methoxymethcathinone, PMMC, Methoxyphedrine, 4-Methedrone | 0,001 g | 0,001 g - 0,1 g |
| 553. | alpha-Pyrrolidinopropiophenone / alpha-PPP / C13H17NO / 1-phenyl-2-(pyrrolidin-1-yl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 554. | alpha-PPP-MeO / C14H19NO2 / 3-methoxy-1-phenyl-2-(pyrrolidin-1-yl)propan-1-one sau PMeOPP | 0,001 g | 0,001 g - 0,1 g |
| 555. | 3-fluoromethcathinone / 3-FMC / C10H12FNO / 1-(3-Fluorophenyl)-2-(methylamino)propan-1-one sau Fluphedrone | 0,001 g | 0,001 g - 0,1 g |
| 556. | Ethylcathinone / Ethcathinone / C11H15NO / 2-(ethylamino)-1-phenyl-1-propanone sau N-Ethylcathinone | 0,001 g | 0,001 g - 0,1 g |
| 557. | 3',4'-Methylenedioxy-alpha-PPP / MDPPP / C14H17NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 558. | 4'-Methoxy-alpha-PPP / MOPPP / C14H19NO2 / 1-(4-Methoxyphenyl)-2-(pyrrolidin-1-yl)propan-1-one sau MeOPPP, pMPPP, 4′-Methoxy-α-pyrrolidinopropiophenone | 0,001 g | 0,001 g - 0,1 g |
| 559. | 4'-Methyl-alpha-pyrrolidinohexanophenone / MPHP / C17H25NO / 1-(4-Methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one sau 4′-Methyl-α-pyrrolidinohexanophenone | 0,001 g | 0,001 g - 0,1 g |
| 560. | MPHP-2201 / C24H27FN2O3 / methyl (1-(5-fluoropentyl)-1H-indole-3-carbonyl)phenylalaninate, methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3-phenylpropanoate sau 5F-MPP-PICA, 5F-MPhP-PICA | 0,001 g | 0,001 g - 0,1 g |
| 561. | Ethylone / bk-MDEA / C12H15NO3 / 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one1-(1,3-Benzodioxol-5-yl)-2-(ethylamino)propan-1-one sau EtONE, Ethylone, 3,4-Methylenedioxyethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 562. | McPT / MCPT / C14H18N2 / N-[2-(1H-Indol-3-yl)ethyl]-N-methylcyclopropanamine | 0,001 g | 0,001 g - 0,1 g |
| 563. | AL-LAD / C22H27N3O / N,N-Diethyl-6-(prop-2-en-1-yl)-9,10-didehydroergoline-8β-carboxamide; (6aR,9R)-N,N-Diethyl-7-(prop-2-en-1-yl)-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamid sau AL-LAD; ALLAD; 6-Allyl-N,N-diethyl-6-norlysergamide; N-Allyl-nor-LSD; N-(6)-Allylnorlysergic acid, N,N-diethylamide; 9,10-Didehydro-6-allyl-N,N-diethylergoline-8β-carboxamide; N,N-Diethylnorlysergamide, 6-allyl; 6-Norlysergamide, 6-allyl-N,N-diethyl | 0,001 g | 0,001 g - 0,1 g |
| 564. | 5-MeO-EIPT / C16H24N2O / N-Ethyl-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]propan-2-amine sau 5-Methoxy-N-ethyl-N-isopropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 565. | 5-MeO-NiPT/ 5-MeO-NIPT / C14H20N2O / N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]propan-2-amine sau N-Isopropyl-5-methoxytryptamine | 0,001 g | 0,001 g - 0,1 g |
| 566. | 5-MeO-MALT / C15H20N2O / N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 567. | 2-Me-DMT / C13H18N2 / N,N-Dimethyl-2-(2-methyl-1H-indol-3-yl)ethan-1-amine sau Desmethoxy-Indapex; 3-[2-(Dimethylamino)ethyl]-2-methylindole; Indole, 3-[2-(dimethylamino)ethyl]-2-methyl; 2,N,N-TMT; 2,N,N-Trimethyltryptamine; Tryptamine, 2,N,N-trimethyl | 0,001 g | 0,001 g - 0,1 g |
| 568. | 4-AcO-DPT/ C18H26N2O2 / 3-[2-(Dipropylamino)ethyl]-1H-indol-4-yl acetate sau 4-Acetoxy-N,N-dipropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 569. | 4-HO-DPT / C16H24N2O / 3-(2-(dipropylamino)ethyl)-1H-indol-4-ol sau 4-Hydroxy-dipropyltryptamine; N,N-Dipropyl-4-hydroxytryptamine | 0,001 g | 0,001 g - 0,1 g |
| 570. | 5-MeO-MET / C14H20N2O / N-Ethyl-2-(5-methoxy-1H-indol-3-yl)-N-methylethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 571. | 6-MeO-DIPT / C17H26N2O / N-isopropyl-N-(2-(6-methoxy-1H-indol-3-yl)ethyl)propan-2-amine sau 6-Methoxy-N,N-diisopropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 572. | 4-AcO-DALT / C18H22N2O2 / -{2-[Di(prop-2-en-1-yl)amino]ethyl}-1H-indol-4-yl acetate sau 4-Acetoxy-N,N-diallyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 573. | 5-MeO-DPT / C17H26N2O / N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine sau 5-Methoxy-N,N-dipropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 574. | 4-AcO-MET / Metacetin / C15H20N2O2 / 3-{2-[Ethyl(methyl)amino]ethyl}-1H-indol-4-yl acetate sau 4-Acetoxy-N-ethyl-N-methyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 575. | 5-HO-DMT / Bufotenine / C12H16N2O / 3-[2-(Dimethylamino)ethyl]-1H-indol-5-ol sau Mappine Tryptamine, N,N-dimethyl-5-hydroxy | 0,001 g | 0,001 g - 0,1 g |
| 576. | 4-HO-MIPT / Miprocin / C14H20N2O / -{2-[Methyl(propan-2-yl)amino]ethyl}-1H-indol-4-ol sau 4-Hydroxy-N-isopropyl-N-methyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 577. | 5-MeO-DET / C15H22N2O / N,N-Diethyl-2-(5-methoxy-1H-indol-3-yl)ethan-1-amine sau N,N-Diethyl-5-methoxytryptamine | 0,001 g | 0,001 g - 0,1 g |
| 578. | 4-AcO-DET / C16H22N2O2 / 3-[2-(Diethylamino)ethyl]-1H-indol-4-yl acetate sau Ethacetin, Ethylacybin | 0,001 g | 0,001 g - 0,1 g |
| 579. | DPT / C16H24N2 / N-[2-(1H-Indol-3-yl)ethyl]-N-propylpropan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 580. | 4-AcO-DPT / C18H26N2O2 / 3-(2-(dipropylamino)ethyl)-1H-indol-4-yl acetate sau 4-Acetoxy-N,N-dipropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 581. | 5-EtO-DPT / C18H28N2O / N-[2-(5-Ethoxy-1H-indol-3-yl)ethyl]-N-propylpropan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 582. | 4-AcO-MIPT / Mipracetin / C16H22N2O2 / 3-{2-[Methyl(propan-2-yl)amino]ethyl}-1H-indol-4-yl acetat | 0,001 g | 0,001 g - 0,1 g |
| 583. | 5-MeO-DIPT / C17H26N2O / N-[2-(5-Methoxy-1H-indol-3-yl) ethyl]-N-(propan-2-yl) propan-2-amine sau N ,N-Diisopropyl-5-methoxytryptamine | 0,001 g | 0,001 g - 0,1 g |
| 584. | 4-AcO-DIPT sau 3-(2-(diisopropylamino) ethyl)-1H-indol-4-yl acetate sau Ipracetin, 4-Acetoxy-DIPT | 0,001 g | 0,001 g - 0,1 g |
| 585. | MIPT / C14H20N2 / N-[2-(1H-Indol-3-yl)ethyl]-N-methylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 586. | 4-HO-DIPT / C16H24N2O / 3-{2-[Di(propan-2-yl)amino]ethyl}-1H-indol-4-ol; 3-(2-(diisopropylamino)ethyl)-1H-indol-4-ol sau Iprocin | 0,001 g | 0,001 g - 0,1 g |
| 587. | 5,6-MDO-MIPT / C15H20N2O2 / N-[2-(5H-[1,3]Dioxolo[4,5-f]indol-7-yl)ethyl]-N-methylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 588. | 5-Me-MIPT / C15H22N2 / N-Methyl-N-[2-(5-methyl-1H-indol-3-yl)ethyl]propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 589. | 4-HO-DET / C14H20N2O / -[2-(Diethylamino)ethyl]-1H-indol-4-o sau Ethocin, CZ-74 | 0,001 g | 0,001 g - 0,1 g |
| 590. | DIPT / C16H24N2 / N-[2-(1H-Indol-3-yl)ethyl]-N-(propan-2-yl)propan-2-amine sau N,N-Diisopropyltryptamine | 0,001 g | 0,001 g - 0,1 g |
| 591. | 5-MeO-AMT / C12H16N2O / 1-(5-Methoxy-1H-indol-3-yl)propan-2-amine sau Alpha-O; α,O-Dimethylserotonin | 0,001 g | 0,001 g - 0,1 g |
| 592. | 4-methoxybutyrfentanyl / 4-MeO-BF / C24H32N2O2 / N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide | 0,001 g | 0,001 g - 0,1 g |
| 593. | Despropionyl-2-fluoro fentanyl / C19H23FN2 / N-(2-fluorophenyl)-1-(2-phenylethyl) piperidin-4-amine | 0,001 g | 0,001 g - 0,1 g |
| 594. | U-47700 / C16H22Cl2N2O / 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide | 0,001 g | 0,001 g - 0,1 g |
| 595. | Methene-U-47700 / C17H24Cl2N2O / 2-(3,4-dichlorophenyl)-N-(2-(dimethylamino)cyclohexyl)-N-methylacetamide sau U-51754 | 0,001 g | 0,001 g - 0,1 g |
| 596. | Isopropyl-U-47700 / C18H26Cl2N2O / 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-(propan-2-yl)benzamide | 0,001 g | 0,001 g - 0,1 g |
| 597. | N-desmethyl-U-47700 / C15H20Cl2N2O / 3,4-dichloro-N-methyl-N-[(1R,2R)-2-(methylamino)cyclohexyl]benzamide | 0,001 g | 0,001 g - 0,1 g |
| 598. | W-18 / C19H20ClN3O4S / 4-Chloro-N-{1-[2-(4-nitrophenyl)ethyl]piperidin-2-ylidene}benzene-1-sulfonamide | 0,001 g | 0,001 g - 0,1 g |
| 599. | Acetylfentanyl / C21H26N2O / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide | 0,001 g | 0,001 g - 0,1 g |
| 600. | Cyclopropylacetylfentanyl / C24H30N2O / 2-Cyclopropyl-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide | 0,001 g | 0,001 g - 0,1 g |
| 601. | Ethoxyacetylfentanyl / C23H30N2O2 / 2-Ethoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide | 0,001 g | 0,001 g - 0,1 g |
| 602. | Methoxyacetylfentanyl / C22H28N2O2 / 2-Methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide sau Methoxyacetyl-F | 0,001 g | 0,001 g - 0,1 g |
| 603. | 4-fluoro-butyrfentanyl / 4F-BF / C23H29FN2O / 1-((4-fluorophenyl)(1-phenethylpiperidin-4-yl)amino)butan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 604. | 2-FIBF / C23H29FN2O / N-(2-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propenamide sau 2-Fluoroisobutyryl fentanyl | 0,001 g | 0,001 g - 0,1 g |
| 605. | 4F-IBF / C23H29FN2O / N-(4-Fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)piperidin-4-yl]propenamide sau p-Fluoro-isobutyrylfentanyl | 0,001 g | 0,001 g - 0,1 g |
| 606. | MT-45 / C24H32N2 / 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine | 0,001 g | 0,001 g - 0,1 g |
| 607. | 2F-MT-45 / C24H31FN2 / 1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine sau 2-fluoro I-C6 | 0,001 g | 0,001 g - 0,1 g |
| 608. | 3F-MT-45 / C24H31FN2 / 1-Cyclohexyl-4-[1-(3-fluorophenyl)-2-phenylethyl]piperazine | 0,001 g | 0,001 g - 0,1 g |
| 609. | W-15 / C19H21ClN2O2S / 4-Chloro-N-[1-(2-phenylethyl)piperidin-2-ylidene]benzene-1-sulfonamide | 0,001 g | 0,001 g - 0,1 g |
| 610. | (Iso)butyryl-F-fentanyl N-benzyl analogue / C22H27FN2O / 2-methyl-N-(1-benzylpiperidin-4-yl)-N-(4-fluorophenyl)propanamide | 0,001 g | 0,001 g - 0,1 g |
| 611. | Phenetrazine / C12H17NO / 3-ethyl-2-phenylmorpholine | 0,001 g | 0,001 g - 0,1 g |
| 612. | 3F-Phenetrazine / C12H16FNO / 3-ethyl-2-(3-fluorophenyl)morpholine | 0,001 g | 0,001 g - 0,1 g |
| 613. | 4-MPH sau 3-methyl-2(p-tolyl)morpholine sau Mephenmetrazine; 4-methylphenmetrazine | 0,001 g | 0,001 g - 0,1 g |
| 614. | 3,4-DMAR / C11H14N2O / 3,4-Dimethyl-5-phenyl-1,3-oxazolidin-2-imine sau 3,4-Dimethylaminorex | 0,001 g | 0,001 g - 0,1 g |
| 615. | N-methyl aminorex derivativ / C10H12N2O / 3-Methyl-5-phenyl-1,3-oxazolidin-2-imine sau 3-Methylaminorex; 3-MAR; 5-phenyl-2-amino-N-methyl-oxazoline | 0,001 g | 0,001 g - 0,1 g |
| 616. | 4-methylpentan-2-amine / DMBA / C6H15N / 4-methylpentan-2-amine sau 1,3-DMBA; 1,3-Dimethylbutylamine | 0,001 g | 0,001 g - 0,1 g |
| 617. | Modafinil sulphone / C15H15NO3S / 2-(Diphenylmethanesulfonyl)acetamide sau CRL-41056 | 0,001 g | 0,001 g - 0,1 g |
| 618. | Flmodafinil / C15H13F2NO2S / 2-[Bis(4-fluorophenyl)methanesulfinyl]acetamide sau CRL-40,940 | 0,001 g | 0,001 g - 0,1 g |
| 619. | Afloqualone / C16H14FN3O / 6-Amino-2-(fluoromethyl)-3-(2-methylphenyl)quinazolin-4(3H)-one | 0,001 g | 0,001 g - 0,1 g |
| 620. | Modafiendz / C16H15F2NO2S / 2-[Bis(4-fluorophenyl)methanesulfinyl]-N-methylacetamide sau N-Methylbisfluoromodafinil | 0,001 g | 0,001 g - 0,1 g |
| 621. | Methylmethaqualone / MMQ / C17H16N2O / 3-(2,4-Dimethylphenyl)-2-methylquinazolin-4(3H)-one | 0,001 g | 0,001 g - 0,1 g |
| 622. | NPDPA / C17H21N / N-(1,2-Diphenylethyl)propan-2-amine sau Isophenidine, Isopropylphenidine | 0,001 g | 0,001 g - 0,1 g |
| 623. | Mesembrine / C17H23NO3 / 3a-(3,4-Dimethoxyphenyl)-1-methyloctahydro-6H-indol-6-one | 0,001 g | 0,001 g - 0,1 g |
| 624. | Diphenidine / C19H23N / 1-(1,2-Diphenylethyl)piperidine sau 1,2-DEP; DPH; DPP | 0,001 g | 0,001 g - 0,1 g |
| 625. | 2-Chlorodiphenidine / C19H22ClN / 1-[1-(2-Chlorophenyl)-2-phenylethyl]piperidine sau 2-Cl-DPH; 2-Cl-DPP | 0,001 g | 0,001 g - 0,1 g |
| 626. | 3-Methoxydiphenidine / C20H25NO / 1-[1-(3-Methoxyphenyl)-2-phenylethyl]piperidine sau 3-MXP | 0,001 g | 0,001 g - 0,1 g |
| 627. | Embutramide / C17H27NO3 / N-[2-Ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxybutanamide | 0,001 g | 0,001 g - 0,1 g |
| 628. | Sibutramine / C17H26ClN / 1-[1-(4-Chlorophenyl)cyclobutyl]-N,N,3-trimethylbutan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 629. | Nitracaine / C16H24N2O4 / 3-(Diethylamino)-2,2-dimethylpropyl 4-nitrobenzoate | 0,001 g | 0,001 g - 0,1 g |
| 630. | RH-34 / C18H19N3O3 /3-(2-{[(2-Methoxyphenyl)methyl]amino}ethyl)quinazoline-2,4(1H,3H)-dione | 0,001 g | 0,001 g - 0,1 g |
| 631. | Mebroqualone / C15H11BrN2O / 3-(2-bromophenyl)-2-methylquinazolin-4(3H)-one | 0,001 g | 0,001 g - 0,1 g |
| 632. | Mephtetramine / MTTA / C12H15NO / 2-[(Methylamino)methyl]-3,4-dihydronaphthalen-1(2H)-one | 0,001 g | 0,001 g - 0,1 g |
| 633. | NMP / C10H9NO2 / 2-(Methylamino)-1H-indene-1,3(2H)-dione sau N-Methylphthalimide | 0,001 g | 0,001 g - 0,1 g |
| 634. | para-Methyl-4-methylaminorex/4,4′-DMAR / C11H14N2O / 4,5-Dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine | 0,001 g | 0,001 g - 0,1 g |
| 635. | 4-methylphendimetrazine / C13H19NO / 3,4-Dimethyl-2-(4-methylphenyl)morpholine | 0,001 g | 0,001 g - 0,1 g |
| 636. | 4-Fluoroephedrine / C10H14FNO / (1R,2S)-1-(4-Fluorophenyl)-2-(methylamino)propan-1-ol | 0,001 g | 0,001 g - 0,1 g |
| 637. | 1-cyclohexyl-x-methoxybenzene / C13H18O / 1-(x-methoxyphenyl)cyclohexanol | 0,001 g | 0,001 g - 0,1 g |
| 638. | 3-Fluoro-isomethcathinone / 3-FiMC / C10H12FNO / 1-(3-Fluorophenyl)-1-(methylamino)propan-2-one | 0,001 g | 0,001 g - 0,1 g |
| 639. | Camfetamine / C14H19N / N-methyl-3-phenyl-norbornan-2-amine sau CFA | 0,001 g | 0,001 g - 0,1 g |
| 640. | 5-HTP / C12H17NO / (2S)-2-Amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid sau 5-Hydroxytryptophan; α-Carboxy-5-hydroxytryptamine | 0,001 g | 0,001 g - 0,1 g |
| 641. | Iso-ethcathinone / C11H15NO / 1-(Ethylamino)-1-phenylpropan-2-one | 0,001 g | 0,001 g - 0,1 g |
| 642. | DMAA / C10H13NO / 2-(Dimethylamino)-1-phenylethan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 643. | Etaqualone / C17H16N2O / 3-(2-Ethylphenyl)-2-methylquinazolin-4(3H)-one | 0,001 g | 0,001 g - 0,1 g |
| 644. | Etaqualone 3-ethylphenyl analog / C17H16N2O / 3-(3-ethylphenyl)-2-methylquinazolin-4(3H)-one | 0,001 g | 0,001 g - 0,1 g |
| 645. | pFBT / C15H18FNO2 / 8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 4-fluorobenzoate sau Fluorotropacocaine | 0,001 g | 0,001 g - 0,1 g |
| 646. | DXM / C18H25NO / 3-Methoxy-17-methyl-9α,13α,14α-morphinan sau Dextromethorphan | 0,001 g | 0,001 g - 0,1 g |
| 647. | 25C-NBF sau 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethan-1-amine sau 2C-C-NBF | 0,001 g | 0,001 g - 0,1 g |
| 648. | DOPR / C14H23NO2 / 1-(2,5-Dimethoxy-4-propylphenyl)propan-2-amine sau 4-Propyl-2,5-dimethoxyamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 649. | 4,3,5-DOPR / C14H23NO2 / 1-(3,5-Dimethoxy-4-propylphenyl)propan-2-amine sau 2,5-Dimethoxy-4-propylamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 650. | DOF / C11H16FNO2 / 1-(4-fluoro-2,5-dimethoxyphenyl)propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 651. | 4-CMA / C10H14ClN / 4-chloro-N,α-dimethyl-benzeneethanamine sau 4-Chloromethamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 652. | DOIP / C14H23NO2 / 1-[2,5-dimethoxy-4-(propan-2-yl)phenyl]propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 653. | 2C-TFM / C11H14F3NO2 / 2,5-dimethoxy-4-(trifluoromethyl)-benzeneethanamine sau 2C-CF3 | 0,001 g | 0,001 g - 0,1 g |
| 654. | 25I-NBF / C17H19FINO2 / N-(2-fluorobenzyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine sau 25I-NB2F; 2C-I-NBF | 0,001 g | 0,001 g - 0,1 g |
| 655. | 25I-NB34MD / C18H20INO4 / N-(1,3-Benzodioxol-5-ylmethyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 656. | 2-Chloro-4,5-MDMA / C11H14ClNO2 / 1-(6-Chloro-2H-1,3-benzodioxol-5-yl)-N-methylpropan-2-amine sau 6-Chloro-MDMA | 0,001 g | 0,001 g - 0,1 g |
| 657. | MMA / meta-Methoxyamphetamine / C10H15NO / 1-(3-methoxyphenyl)propan-2-amine sau 3-methoxyamphetamine; 3-MA | 0,001 g | 0,001 g - 0,1 g |
| 658. | 3-Methoxy-4-methylamphetamine / C11H17NO / 1-(3-Methoxy-4-methylphenyl)propan-2-amine sau 3,4-MMA; 3-Methoxy-4-methylamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 659. | 4-EA NBOMe / C19H25NO / 1-(4-Ethylphenyl)-N-[(2-methoxyphenyl)methyl]propan-2-amine sau 4-Ethyl-N-(o-methoxybenzyl)amphetamine | 0,001 g | 0,001 g - 0,1 g |
| 660. | 3,4-DMA NBOMe / C19H25NO3 / 1-(3,4-Dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 661. | EFLEA / C12H17NO3 / 1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-N-hydroxy-N-methylpropan-2-amine sau N-Hydroxy-N-methyl-3,4-ethylenedioxyamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 662. | bk-3,4-MDPA / Propylone / C13H17NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(propylamino)propan-1-one sau 3,4-methylenedioxy-N-propylcathinone | 0,001 g | 0,001 g - 0,1 g |
| 663. | 4-bromoamphetamine (4-BA) / C9H12BrN / 1-(4-Bromophenyl)propan-2-amine sau PBA | 0,001 g | 0,001 g - 0,1 g |
| 664. | 2-methoxyamphetamine / C10H15NO / 1-(2-Methoxyphenyl)propan-2-amine sau 2-MA; 2-MeO-AMP; NDMP | 0,001 g | 0,001 g - 0,1 g |
| 665. | 6-Bromo-MDMA / C11H14BrNO2 / 1-(6-Bromo-2H-1,3-benzodioxol-5-yl)-N-methylpropan-2-amine sau 2-Br-4,5-MDMA; 6-Br-MDMA | 0,001 g | 0,001 g - 0,1 g |
| 666. | N-methyl-2C-B / C11H16BrNO2 / 4-Bromo-N-methyl-2,5-dimethoxyphenethylamine; 2-(4-bromo-2,5-dimethoxyphenyl)-N-methylethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 667. | Methallylescaline / C14H21NO3 / 2-{3,5-Dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl}ethan-1-amine sau MAL | 0,001 g | 0,001 g - 0,1 g |
| 668. | 30C-NBOMe / C20H26ClNO5 / 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(3,4,5-trimethoxybenzyl)ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 669. | 3C-E / C13H21NO3 / 1-(4-Ethoxy-3,5-dimethoxyphenyl)propan-2-amine sau 4-Ethoxy-3,5-dimethoxyamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 670. | 3C-P / C14H23NO3 / 1-(3,5-Dimethoxy-4-propoxyphenyl)propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 671. | 25I-NBMD / C18H20INO4 / N-(1,3-Benzodioxol-4-ylmethyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethan-1-amine sau 2C-I-NBMD; Cimbi-29; 25I-DMBD | 0,001 g | 0,001 g - 0,1 g |
| 672. | Proscaline / C13H21NO3 / 2-(3,5-Dimethoxy-4-propoxyphenyl)ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 673. | 2-(2,3-dimethoxyphenyl)-N-(3,4,5-trimethoxybenzyl)ethanamine / C20H27NO5 / 2-(2,3-dimethoxyphenyl)-N-(3,4,5-trimethoxybenzyl)ethanamine sau 2,3-DMPEA-NBTOMe | 0,001 g | 0,001 g - 0,1 g |
| 674. | AL – allylescaline / C13H19NO3 / 2-[3,5-Dimethoxy-4-(prop-2-en-1-yloxy) phenyl] ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 675. | Escaline / C12H19NO3 / 2-(4-Ethoxy-3,5-dimethoxyphenyl)ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 676. | N-ethyl-1-phenylbutan-2-amine / C12H19N / N-ethyl-1-phenylbutan-2-amine sau N-ethyl-1-phenethyl-2-butylamine | 0,001 g | 0,001 g - 0,1 g |
| 677. | 25H-NBOMe / C18H23NO3 / 2-(2,5-Dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl] ethan-1-amine sau DMPEA-NBOMe; 2C-H-NBOMe | 0,001 g | 0,001 g - 0,1 g |
| 678. | 4-chloroamphetamine/4-CA / C9H12ClN / 1-(4-Chlorophenyl)propan-2-amine sau 4-Cl-AMP; PCA | 0,001 g | 0,001 g - 0,1 g |
| 679. | 4-Hydroxyamphetamine / C9H13NO / 4-(2-Aminopropyl)phenol sau 4-OH-A; PHA | 0,001 g | 0,001 g - 0,1 g |
| 680. | 2C-G / C12H19NO2 / 2-(2,5-Dimethoxy-3,4-dimethylphenyl)ethan-1-amine sau 2,5-Dimethoxy-3,4-dimethylphenethylamine | 0,001 g | 0,001 g - 0,1 g |
| 681. | 2C-N / C10H14N2O4 / 2-(2,5-Dimethoxy-4-nitrophenyl)ethan-1-amine sau 2,5-Dimethoxy-4-nitrophenethylamine | 0,001 g | 0,001 g - 0,1 g |
| 682. | 25E-NBOMe / C20H27NO3 / 2-(4-Ethyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethan-1-amine sau 25E-NBOMe | 0,001 g | 0,001 g - 0,1 g |
| 683. | 25G-NBOMe / C20H27NO3 / 2-(2,5-Dimethoxy-3,4-dimethylphenyl)-N-(2-methoxybenzyl) ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 684. | 25N-NBOMe / C18H22N2O5 / 2-(2,5-Dimethoxy-4-nitrophenyl)-N-(2-methoxybenzyl)ethan-1-amine sau 2C-N-NBOMe | 0,001 g | 0,001 g - 0,1 g |
| 685. | MDDM / C12H17NO2 / 1-(1,3-Benzodioxol-5-yl)-N,N-dimethylpropan-2-amine sau N,N-Dimethyl-MDA | 0,001 g | 0,001 g - 0,1 g |
| 686. | 2-FMA / C10H14FN / 1-(2-Fluorophenyl)-N-methylpropan-2-amine sau 2-Fluoromethamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 687. | N-Propylamphetamine/PA / C12H19N / 1-phenyl-N-propylpropan-2-amine sau d-N-Propylamphetamine; Propylamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 688. | DMMA / C12H19NO2 / 1-(3,4-Dimethoxyphenyl)-N-methylpropan-2-amine sau Dimethoxymethamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 689. | Dimethylamphetamine / C11H17N / N,N-Dimethyl-1-phenylpropan-2-amine sau Metrotonin; DIMETH; N,N-Dimethylamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 690. | ß-Me-PEA / C9H13N / 2-Phenylpropylamine sau 2-Phenylpropylamine; beta-Methylphenethylamine | 0,001 g | 0,001 g - 0,1 g |
| 691. | N,N-dimethylphenethylamine / C10H15N / N,N-Dimethyl-2-phenylethan-1-amine sau N,N-DMPEA; N,N-MePEA | 0,001 g | 0,001 g - 0,1 g |
| 692. | 4-FMA sau 4-Fluoromethamphetamine; 4F-MA | 0,001 g | 0,001 g - 0,1 g |
| 693. | 3-FMA / C10H14FN / 1-(3-Fluorophenyl)-N-methylpropan-2-amine sau 3-Fluoromethamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 694. | TMA-6 / C12H19NO3 / 1-(2,4,6-Trimethoxyphenyl)propan-2-amine sau 2,4,6-Trimethoxyamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 695. | 3- fluoroamphetamine /3-FA / C9H12FN / 1-(3-Fluorophenyl)propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 696. | 4-Fluoroamphetamine/4-FA / C9H12FN / 1-(4-Fluorophenyl)propan-2-amine sau 4-FA; 4F-AMP | 0,001 g | 0,001 g - 0,1 g |
| 697. | N-Acetyl-DOB / C13H18BrNO3 / N-[1-(4-Bromo-2,5-dimethoxyphenyl)propan-2-yl]acetamide sau DOB-Ac | 0,001 g | 0,001 g - 0,1 g |
| 698. | PMEA / C12H19NO / N-Ethyl-1-(4-methoxyphenyl)propan-2-amine sau N-Et-PMA; p-Methoxyethylamphetamine | 0,001 g | 0,001 g - 0,1 g |
| 699. | NMPEA / C9H13N / N-Methyl-2-phenylethan-1-amine sau N-Methylphenethylamine | 0,001 g | 0,001 g - 0,1 g |
| 700. | 2,4-DMA / C12H19NO / N-Ethyl-1-(4-methoxyphenyl)propan-2-amine sau N-Et-PMA; PMEA | 0,001 g | 0,001 g - 0,1 g |
| 701. | 2C-E / C12H19NO2 / 2-(4-Ethyl-2,5-dimethoxyphenyl)ethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 702. | 2C-D / C11H17NO2 / 2,5-Dimethoxy-4-methylphenethylamine; LE-25 | 0,001 g | 0,001 g - 0,1 g |
| 703. | 2C-P / C13H21NO2 / 2-(2,5-Dimethoxy-4-propylphenyl)ethan-1-amine sau Selene; 2,5-Dimethoxy-4-n-propylphenethylamine | 0,001 g | 0,001 g - 0,1 g |
| 704. | Pyrrole, 1-tert-butyl-2, 4-diphenyl / C20H21N / Pyrrole, 1-tert-butyl-2, 4-diphenyl | 0,001 g | 0,001 g - 0,1 g |
| 705. | MDMB-4en-PINACA / C20H27N3O3 / Methyl (2S)-3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate sau MDMB(N)-022, ADB-PINACA-A | 0,001 g | 0,001 g - 0,1 g |
| 706. | 8-Amino–5–[S-hexylthio]–6–methoxy–2–methylquniloine / C17H24N2OS / 8-Amino–5–[S-hexylthio]–6–methoxy–2–methylquniloine | 0,001 g | 0,001 g - 0,1 g |
| 707. | MDPPP / 3′,4′–Methylenedioxy – α – pyrrolidinopropiophenone / C14H17NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)propan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 708. | P2NP / 1-Phenyl–2-nitropropene / C9H9NO2 / 2-nitroprop-1-en-1-yl benzene sau Methylnitrostyrene | 0,001 g | 0,001 g - 0,1 g |
| 709. | Eutylone / β – Keto-1,3 – benzodioxolyl – N – ethylbutanamine / C13H17NO3 / 1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one sau bk-EBDB | 0,001 g | 0,001 g - 0,1 g |
| 710. | 1–(4–Chlorophenyl)–2–(N-ethylamino)propan–1–one / C11H14C1NO / 1–(4–Chlorophenyl)–2–(N-ethylamino)propan–1–one sau 4-CEC; 4-Chloroethcathinone | 0,001 g | 0,001 g - 0,1 g |
| 711. | α – Propylaminopentiophenone / C14H21NO / 1-Phenyl-2-[(propan-2-yl)amino]pentan-1-one sau N-PP; N-Propylpentedrone | 0,001 g | 0,001 g - 0,1 g |
| 712. | 2 – Pyrrolidino – 4bicyclo - methylacetophe | 0,001 g | 0,001 g - 0,1 g |
| 713. | 4′ – chloro – α – Pyrrolidinovalerophenone / C15H20C1NO / 1-(4-chlorophenyl)-2-(pyrrolidin-1-yl)pentan-1-one sau 4-chloro-α-PVP, 4Cl-PVP, 4C-PVP | 0,001 g | 0,001 g - 0,1 g |
| 714. | Parafluorobutyrylfentanyl / C23H29FN2O / N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide sau 4-Fluorobutyrfentanyl | 0,001 g | 0,001 g - 0,1 g |
| 715. | Ortho-fluorofentanyl / C22H27FN2O / N-(2-Fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide | 0,001 g | 0,001 g - 0,1 g |
| 716. | Methoxyacetyl fentanyl / C22H28N2O2 / 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide sau MAF | 0,001 g | 0,001 g - 0,1 g |
| 717. | Cyclopropylfentanyl / C23H28N2O / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]cyclopropanecarboxamide | 0,001 g | 0,001 g - 0,1 g |
| 718. | CUMYL-4CN-BINACA / C22H24N4O / 1-(4-Cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide sau CUMYL-CYBINACA; SGT-78 | 0,001 g | 0,001 g - 0,1 g |
| 719. | N-Ethylnorpentylone (ephylone) / C14H19NO3 / 1-(2H-1,3-Benzodioxol-5-yl)-2-(ethylamino)pentan-1-one sau MDEVP; bk-EBDP | 0,001 g | 0,001 g - 0,1 g |
| 720. | Paramethoxybutyrylfentanyl / C24H32N2O2 / N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide sau 4-Methoxybutyrylfentanyl | 0,001 g | 0,001 g - 0,1 g |
| 721. | MPA/methylthienylpropamine / C8H13NS / N-Methyl-1-(thiophen-2-yl)propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 722. | AMB-FUBINACA / C21H22FN3O3 / methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazol-3-yl}formamido)-3-methylbutanoate sau FUB-AMB | 0,001 g | 0,001 g - 0,1 g |
| 723. | Fentanyl butanamide analog / C23H30N2O / N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide sau Butyrfentanyl; Butyrylfentanyl | 0,001 g | 0,001 g - 0,1 g |
| 724. | Alpha-methylfentanyl butanamide analog / C24H32N2O / N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenyl-butanamide sau alpha-methylbutyryl fentanyl | 0,001 g | 0,001 g - 0,1 g |
| 725. | Orthofluorofentanyl / C22H27FN2O / N-(2-Fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | 0,001 g | 0,001 g - 0,1 g |
| 726. | m-Fluorofentanyl / C22H27FN2O / N-(3-Fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide | 0,001 g | 0,001 g - 0,1 g |
| 727. | Benocyclidine / C19H25NS / 1-[1-(1-Benzothiophen-2-yl)cyclohexyl]piperidine sau BTCP, BCP | 0,001 g | 0,001 g - 0,1 g |
| 728. | Methoxyketamine / C14H19NO2 / 2-(2-Methoxyphenyl)-2-(methylamino)cyclohexan-1-one sau 2-MDCK | 0,001 g | 0,001 g - 0,1 g |
| 729. | Furanylfentanyl / C24H26N2O2 / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide sau Fu-F | 0,001 g | 0,001 g - 0,1 g |
| 730. | Diclazepam / C16H12Cl2N2O / 7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | 0,001 g | 0,001 g - 0,1 g |
| 731. | Clonazolam / C17H12ClN5O2 / 6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine sau Clonitrazolam | 0,001 g | 0,001 g - 0,1 g |
| 732. | 550/ Pyrazolam / C16H12BrN5 / 8-bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine | 0,001 g | 0,001 g - 0,1 g |
| 733. | Mimosa tenuiflora: | ||
| - uscată | 1 g | 1 g – 300 g | |
| - verde | 10 g | 10g – 500 g | |
| 734. | ATHPINACA / C24H31N3O2 / N-(Adamantan-1-yl)-1-[(oxan-4-yl)methyl]-1H-indazole-3-carboxamide sau Adamantyl-THPINACA | 0,001 g | 0,001 g - 0,1 g |
| 735. | HOT-7 / C13H21NO3S / 2-[2,5-Dimethoxy-4-(propylsulfanyl)phenyl]-N-hydroxyethan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 736. | SCH-5472 / C19H23NO / 2-(Diphenylmethyl)-1-methylpiperidin-3-ol | 0,001 g | 0,001 g - 0,1 g |
| 737. | PSB-SB-1202 / C23H26O4 / 5-Methoxy-3-[(2-methoxyphenyl)methyl]-7-pentyl-2H-1-benzopyran-2-one | 0,001 g | 0,001 g - 0,1 g |
| 738. | 3-CAF / C24H15FN2O2 / Naphthalen-2-yl 1-(2-fluorophenyl)-1H-indazole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 739. | URB-602 / C19H21NO2 / cyclohexyl [1,1'-biphenyl]-3-ylcarbamate | 0,001 g | 0,001 g - 0,1 g |
| 740. | PRE-084 / C19H27NO3 / 2-(Morpholin-4-yl)ethyl 1-phenylcyclohexane-1-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 741. | FLEA / C11H15NO3 / 1-(1,3-Benzodioxol-5-yl)-N-hydroxy-N-methylpropan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 742. | Benzylfentanyl / C21H26N2O / N-(1-Benzylpiperidin-4-yl)-N-phenylpropanamide | 0,001 g | 0,001 g - 0,1 g |
| 743. | 5-APB-NBOMe / C19H21NO2 / 1-(1-Benzofuran-5-yl)-N-[(2-methoxyphenyl)methyl]propan-2-amine | 0,001 g | 0,001 g - 0,1 g |
| 744. | CP 50,556-1 / C27H35NO4 / (6S,6aR,9R,10aR)-9-Hydroxy-6-methyl-3-{[(2R)-5-phenylpentan-2-yl]oxy}-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl acetate sau Levonantradol | 0,001 g | 0,001 g - 0,1 g |
| 745. | D2PM / C17H19NO / Diphenyl(pyrrolidin-2-yl)methanol sau Diphenylprolinol | 0,001 g | 0,001 g - 0,1 g |
| 746. | JB-336 / C20H23NO3 / 1-Methylpiperidin-3-yl hydroxy(diphenyl)acetate | 0,001 g | 0,001 g - 0,1 g |
| 747. | LTI-701 / C20H21FN2O / 1-(5-fluoropentyl)-N-phenyl-1H-indole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 748. | Thenylfentanyl / C19H24N2OS / N-Phenyl-N-{1-[(thiophen-2-yl)methyl]piperidin-4-yl}propanamide | 0,001 g | 0,001 g - 0,1 g |
| 749. | JB-318 / C21H25NO3 / 1-Ethylpiperidin-3-yl hydroxy(diphenyl)acetate sau N-Ethyl-3-piperidyl benzilate | 0,001 g | 0,001 g - 0,1 g |
| 750. | Etaqualone / C17H16N2O / 3-(2-Ethylphenyl)-2-methylquinazolin-4(3H)-one | 0,001 g | 0,001 g - 0,1 g |
| 751. | Nitromethaqualone / C16H13N3O4 / 3-(2-Methoxy-4-nitrophenyl)-2-methylquinazolin-4(3H)-one sau 4-Nitromethaqualone | 0,001 g | 0,001 g - 0,1 g |
| 752. | Adrafinil / C15H15NO3S / 2-(Diphenylmethanesulfinyl)-N-hydroxyacetamide | 0,001 g | 0,001 g - 0,1 g |
| 753. | Aprobarbital / C10H14N2O3 / 5-(prop-2-en-1-yl)-5-(propan-2-yl)-1,3-diazinane-2,4,6-trione | 0,001 g | 0,001 g - 0,1 g |
| 754. | Brallobarbital / C10H11BrN2O3 / 5-(2-bromoprop-2-enyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trionequaz | 0,001 g | 0,001 g - 0,1 g |
| 755. | Heptabarbital / C13H18N2O3 / 5-(cyclohepten-1-yl)-5-ethyl-1,3-diazinane-2,4,6-trione | 0,001 g | 0,001 g - 0,1 g |
| 756. | Quazepam / C17H11ClF4N2S / 7-Chloro-5-(2-fluorophenyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-1,4-benzodiazepine-2-thione | 0,001 g | 0,001 g - 0,1 g |
| 757. | Cloniprazepam / C19H16ClN3O3 / 5-(2-Chlorophenyl)-1-(cyclopropylmethyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one | 0,001 g | 0,001 g - 0,1 g |
| 758. | M-ALPHA / C11H15NO2 / 1-(1,3-Benzodioxol-5-yl)-N-methylpropan-1-amine sau α-Ethyl-N-methylpiperonylamine | 0,001 g | 0,001 g - 0,1 g |
| 759. | Fonazepam / C15H10FN3O3 / 5-(2-Fluorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one sau Norflunitrazepam | 0,001 g | 0,001 g - 0,1 g |
| 760. | Cinazepam / C19H14BrClN2O5 / 4-{[7-Bromo-5-(2-chlorophenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]oxy}-4-oxobutanoic acid | 0,001 g | 0,001 g - 0,1 g |
| 761. | U-51754 / C17H24Cl2N2O / 2-(3,4-dichlorophenyl)-N-(2-(dimethylamino)cyclohexyl)acetamide | 0,001 g | 0,001 g - 0,1 g |
| 762. | MTTA / C12H15NO / 2-[(Methylamino)methyl]-3,4-dihydronaphthalen-1(2H)-one sau Mephtetramine | 0,001 g | 0,001 g - 0,1 g |
| 763. | Isopentedrone / C12H17NO / 1-(Methylamino)-1-phenylpentan-2-one | 0,001 g | 0,001 g - 0,1 g |
| 764. | TCM / C11H17NS / N-Methyl-1-(thiophen-2-yl)cyclohexan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 765. | 3-F-iso-MC / C10H12FNO / 1-(3-Fluorophenyl)-1-(methylamino)propan-2-one | 0,001 g | 0,001 g - 0,1 g |
| 766. | 3-MeO-PCMMo / C18H27NO2 / 4-{[1-(3-Methoxyphenyl) cyclohexyl]methyl}morpholine | 0,001 g | 0,001 g - 0,1 g |
| 767. | MDA-19 / C21H23N3O2 / (1-Hexyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)benzohydrazide | 0,001 g | 0,001 g - 0,1 g |
| 768. | Ibogaine / C20H26N2O / 12-Methoxyibogamine; 7-Ethyl-2-methoxy-6,6a,7,8,9,10,12,13-octahydro-5H-6,9-methanopyrido[1′,2′:1,2]azepino[4,5-b]indole | 0,001 g | 0,001 g - 0,1 g |
| 769. | HU-331 / C21H28O3 / (1'R)-6-hydroxy-3'-methyl-4-pentyl-6'-(prop-1-en-2-yl)-[1,1'-bi(cyclohexane)]-2',3,6-triene-2,5-dione | 0,001 g | 0,001 g - 0,1 g |
| 770. | JWH-133 / C22H32O / 3-(1,1-dimethylbutyl)-6aR,7,10,10aR-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran | 0,001 g | 0,001 g - 0,1 g |
| 771. | HU-308 / C27H42O3 / {(4S)-4-[2,6-Dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl}methanol | 0,001 g | 0,001 g - 0,1 g |
| 772. | URB-597 / C20H22N2O3 / 3′-Carbamoyl[1,1′-biphenyl]-3-yl cyclohexylcarbamate | 0,001 g | 0,001 g - 0,1 g |
| 773. | Harmine / C13H12N2O / 7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole; 7-Methoxy-1-methyl-9H-β-carboline sau Banisterine; Telepathine | 0,001 g | 0,001 g - 0,1 g |
| 774. | Epirocaine / C14H21NO2 / 2-Methyl-2-(propylamino)propyl benzoate sau Oracaine; Meprylcaine | 0,001 g | 0,001 g - 0,1 g |
| 775. | Modafiendz / C16H15F2NO2S / 2-[Bis(4-fluorophenyl)methanesulfinyl]-N-methylacetamide sau Methylbisfluoromodafinil | 0,001 g | 0,001 g - 0,1 g |
| 776. | Benzoylbenzylfentanyl / C25H26N2O / N-(1-Benzylpiperidin-4-yl)-N-phenylbenzamide | 0,001 g | 0,001 g - 0,1 g |
| 777. | Furanylbenzylfentanyl / C23H24N2O2 / N-(1-Benzylpiperidin-4-yl)-N-phenylfuran-2-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 778. | Methyl 1-benzyl-1H-indazole-3-carboxylate / C16H14N2O2 / Methyl 1-benzylindazole-3-carboxylate | 0,001 g | 0,001 g - 0,1 g |
| 779. | U-48800 / C17H24Cl2N2O / 2-(2,4-Dichlorophenyl)-N-(2-(dimethylamino)cyclohexyl)-N-methylacetamide | 0,001 g | 0,001 g - 0,1 g |
| 780. | Thiofentanyl / C20H26N2OS / N-Phenyl-N-{1-[2-(thiophen-2-yl)ethyl]piperidin-4-yl}propenamide sau R-31826 | 0,001 g | 0,001 g - 0,1 g |
| 781. | Brifentanil / C20H29FN6O3 / 1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-3-methylpiperidin-4-yl]-N-(2-fluorophenyl)-2-methoxyacetamide sau A-3331 | 0,001 g | 0,001 g - 0,1 g |
| 782. | Trefentanil / C25H31FN6O2 / N-{1-[2-(4-Ethyl-5-oxo-4,5-dihydro-1H-tetrazol-1-yl)ethyl]-4-phenylpiperidin-4-yl-N-(2-fluorophenyl)propenamide sau A-3665 | 0,001 g | 0,001 g - 0,1 g |
| 783. | Benzoylfentanyl / C26H28N2O / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]benzamide sau Phenylfentanyl | 0,001 g | 0,001 g - 0,1 g |
| 784. | Benzodioxolefentanyl / C27H28N2O3 / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-2H-1,3-benzodioxole-5-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 785. | 3-Furanylfentanyl / C24H26N2O2 / N-Phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 786. | Flualprazolam / C17H12ClFN4 | 0,001 g | 0,001 g - 0,1 g |
| 787. | Crotonylfentanyl / N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-2-butenamide / C23H28N2O | 0,001 g | 0,001 g - 0,1 g |
| 788. | Valerylfentanyl / C24H32N2O / N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]pentanamide | 0,001 g | 0,001 g - 0,1 g |
| 789. | Peganum harmala : | ||
| - uscată | 1 g | 1 g – 300 g | |
| - verde | 10 g | 10g – 500 g | |
| 790. | Banisteriopsis caapi: | ||
| - uscată | 1 g | 1 g – 300 g | |
| - verde | 10 g | 10g – 500 g | |
| 791. | Psychotria viridis: | ||
| - uscată | 1 g | 1 g – 300 g | |
| - verde | 10 g | 10g – 500 g | |
| 792. | Cannabis: | ||
| - răşină de cannabis | 0,05 g | 0,05 g – 10,0 g | |
| - ulei de cannabis sau de haşiş | 0,1 g | 0,1 g – 10,0 g | |
| marijuana: | |||
| - uscată | 2,0 g | 2,0 g - 500 g | |
| - verde | 14,0 g | 14,0 g - 1000 g | |
| - haşiş | 0,5 g | 0,5 g – 50,0 g | |
| 793. | Izumetadom (Isomethadone / 6-(dimethylamino)-5-methyl-4,4-diphenylhexan-3-one) | 0,001 g | 0,001 g - 0,1 g |
| 794. | Levomoramide / 3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1-ylbutan-1-one | 0,001 g | 0,001 g - 0,1 g |
| 795. | AB-CHMINACA sau AB-PINACA-CHM / N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | 0,001 g | 0,001 g - 0,1 g |
| 796. | Fenmetrazin (Phenmetrazine / 3-Methyl-2-phenylmorpholine) | 0,001 g | 0,001 g - 0,1 g |
| 797. | APAAN (alfa-fenylacetoacetonitril) | 0,001 g | 0,001 g - 0,1 g |
| 798. | Pentedrone HCL /C12H17NO·HCI/ | 0,001 g | 0,001 g - 0,1 g |
| 799. | Rhodium, bis(ethylene)-indenyl- (C12H15Rh) | 0,001 g | 0,001 g - 0,1 g |
| 800. | 4-Fluoroisobutyrfentanyl (4-FIBF, pFIBF) | 0,001 g | 0,001 g - 0,1 g |
| 801. | Isotonitazene | 0,001 g | 0,001 g - 0,1 g |
| 802. | Quinoline-4-ol C17H22N2O2 / 6-methoxy-2-methyl-3-(1-piperidylmethyl) | 0,001 g | 0,001 g - 0,1 g |
| 803. | 4-AP N-Phenyl-4-Piperidinamine | 0,001 g | 0,001 g - 0,1 g |
| 804. | Nor fentanyl (N-phenyl-N-(piperidin-4-yl) propenamide) | 0,001 g | 0,001 g - 0,1 g |
|
|
|||
| 1. | Brolamfetamin, DOB | 0,0005 g | 0,0005 g – 0,002 g |
| 2. | Catinon | 0,0005 g | 0,0005 g – 0,002 g |
| 3. | DET | 0,0005 g | 0,0005 g – 0,002 g |
| 4. | DMA | 0,0005 g | 0,0005 g – 0,002 g |
| 5. | DMHP | 0,05 g | 0,05 g – 5,0 g |
| 6. | DMT | 0,0005 g | 0,0005 g – 0,002 g |
| 7. | DOET | 0,0005 g | 0,0005 g – 0,002 g |
| 8. | Eticiclidin, PCE | 0,0001 g | 0,0001 g – 0,01 g |
| 9. | Etriptamin | 0,0005 g | 0,0005 g – 0,002 g |
| 10. | MDMA | 0,05 g | 0,05 g – 5,0 g |
| 11. | Mescaline | 0,05 g | 0,05 g – 5,0 g |
| 12. | 4-Metilaminorex | 0,01 g | 0,01 g – 1,0 g |
| 13. | MMDA | 0,002 g | 0,002 g – 1,0 g |
| 14. | N-etll MDA | 0,002 g | 0,002 g – 1,0 g |
| 15. | N-hidroxi MDA | 0,002 g | 0,002 g – 1,0 g |
| 16. | 4-MTA (4-metiltioamfetamin) | 0,002 g | 0,002 g – 1,0 g |
| 17. | Parahexil | 0,0002 g | 0,0002 g – 0,5 g |
| 18. | PMA | 0,002 g | 0,002 g – 1,0 g |
| 19. | Psilocină, psilotsin | 0,005 g | 0,005 g – 0,1 g |
| 20. | Psilocibin | 0,005 g | 0,005 g – 0,1 g |
| 21. | Roticiclidin | 0,0001 g | 0,0001 g – 0,01 g |
| 22. | STP, DOM | 0,0005 g | 0,0005 g – 0,002 g |
| 23. | Tenamfetamin, MDA | 0,002 g | 0,002 g – 1,0 g |
| 24. | Tenociclidin, TCP | 0,0001 g | 0,0001 g – 0,01 g |
| 25. | TMA | 0,03 g | 0,03 g – 0,3 g |
| 26. | Amfetamin | 0,1 g | 0,1 g – 1,0 g |
| 27. | Amineptin | 0,2 g | 0,2 g – 2,0 g |
| 28. | 2 CB-(4-Bromo-2,5-d metoxifentilentilamin) | 0,05 g | 0,05 g – 0,1 g |
| 29. | Delta-9-tetra-hidrocannahinol şi derivaţii lui | 0,05 g | 0,05 g – 1,0 g |
| 30. | Dexamfetamin | 0,005 g | 0,005 g – 0,1 g |
| 31. | Fenciclidin, PCP | 0,005 g | 0,005 g – 0,1 g |
| 32. | Fenmetrazin (Phenmetrazine / 3-Methyl-2-phenylmorpholine) | 0,05 g | 0,05 g – 1,0 g |
| 33. | Fenetillin | 0,015 g | 0,015 g – 0,15 g |
| 34. | Levamfetamin | 0,005 g | 0,005 g – 0,1 g |
| 35. | Levametamfetamin | 0,005 g | 0,005 g – 0,1 g |
| 36. | Mecloqualon | 0,05 g | 0,05 g – 5,0 g |
| 37. | Metamfetamin | 0,05 g | 0,05 g – 5,0 g |
| 38. | Metamfetamin (substanţă preparată artizanal din efedrină, pseudoefedrină sau din preparate care conţin efedrină sau pseudoefedrină) | 3 ml/0,03 g | 3-50 ml/0,03 g – 5 g |
| 39. | Metamfetamină racemat | 0,05 g | 0,05 g – 5,0 g |
| 40. | Metaqualon | 0,2 g | 0,2 g – 1,0 g |
| 41. | Metilfenidat | 0,03 g | 0,03 g – 0,3 g |
| 42. | Secobarbital | 0,075 g | 0,075 g – 0,75 g |
| 43. | Zipeprol | 0,01 g | 0,01 g – 1,0 g |
| 44. | Amobarbital | 1 g | 1 g – 5 g |
| 45. | Buprenorfin | 0,005 g | 0,005 g – 0,25 g |
| 46. | Butalbital | 0,525 g | 0,525 g – 7,5 g |
| 47. | Catin | 0,2 g | 0,2 g – 1 g |
| 48. | Ciclobarbital | 0,7 g | 0,7 g – 10 g |
| 49. | Flunitrazepam | 0,35 g | 0,35 g – 10 g |
| 50. | Glutetimid | 0,25 g | 0,25 g – 12,5 g |
| 51. | Pentazocin | 2 g | 2 g – 15,0 g |
| 52. | Pentobarbital | 1,5 g | 1,5 g – 2,5 g |
| 53. | Alobarbital | 0,7 g | 0,7 g – 10 g |
| 54. | Alprazolam | 0,007 g | 0,007 g – 5 g |
| 55. | Amfepramon | 0,175 g | 0,175 g – 5 g |
| 56. | Aminorex | 0,7 g | 0,7 g – 10 g |
| 57. | Aprofen | 0,5 g | 0,5 g – 10 g |
| 58. | Barbital | 3,5 g | 3,5 g – 15 g |
| 59. | Benzfetamin | 0,175 g | 0,175 g – 2,5 g |
| 60. | Bromazepam | 0,07 g | 0,07 g – 1 g |
| 61. | Brotizolam | 0,00175 g | 0,00175 g – 0,025 g |
| 62. | Butobarbital | 1,05 g | 1,05 g – 15 g |
| 63. | Camazepam | 0,25 g | 0,25 g – 5 g |
| 64. | Chlordiazepoxid | 0,25 g | 0,25 g – 5 g |
| 65. | Ciclodol | 0,15 g | 0,15 g – 10 g |
| 66. | Clobazam | 0,15 g | 0,15 g – 10 g |
| 67. | Clofelin | 0,35 g | 0,35 g – 10 g |
| 68. | Clonazepam | 0,056 g | 0,056 g – 2 g |
| 69. | Chlorazepate | 0,15 g | 0,15 g – 10 g |
| 70. | Clotiazepam | 0,105 g | 0,105 g – 1 g |
| 71. | Cloxazolam | 0,065 g | 0,065 g – 2 g |
| 72. | Delorazepam | 0,025 g | 0,025 g – 0,3 g |
| 73. | Diazepam | 0,07 g | 0,07 g – 1 g |
| 74. | Droperidol | 0,035 g | 0,035 g – 0,5 g |
| 75. | Dextrometorfan | 0,45 g | 0,45 g – 6 g |
| 76. | Estazolam | 0,025 g | 0,025 g – 0,3 g |
| 77. | Etclorvinol | 3,5 g | 3,5 g – 50 g |
| 78. | Etilnamat | 3,5 g | 3,5 g – 50 g |
| 79. | EliI Loflazepat | 0,015 g | 0,015 g – 10 g |
| 80. | Elilamfetamin | 0,015 g | 0,015 g – 10 g |
| 81. | Fenazepam | 0,01 g | 0,01 g – 0,5 g |
| 82. | Fendimetrazin | 0,35 g | 0,35 g – 20 g |
| 83. | Fenobarbital | 0,7 g | 0,7 g – 50 g |
| 84. | Fentermin | 0,07 g | 0,07 g – 1 g |
| 85. | Fencamfamin | 0,56 g | 0,56 g – 8 g |
| 86. | Fenproporex | 0,15 g | 0,15 g – 10 g |
| 87. | Fludiazepam | 0,00525 g | 0,00525 g – 0,75 g |
| 88. | Flurazepam | 0,25 g | 0,25 g – 3 g |
| 89. | (GNB) Gamma-hidroxibutiric acid | 5,0 g | 5,0 g – 100 g |
| 90. | Halazepam | 0,7 g | 0,7 g – 10 g |
| 91. | Haloxazolam | 0,0525 g | 0,0525 g – 7,5 g |
| 92. | INN (Zalpidem) | 0,07 g | 0,07 g – 1 g |
| 93. | Ketaminum şi sărurile lui | 0,7 g | 0,7 g – 50 g |
| 94. | Ketazolam | 0,25 g | 0,25 g – 10 g |
| 95. | Lefetamin | 0,525 g | 0,525 g – 7,5 g |
| 96. | Loprazolam | 0,007 g | 0,007 g – 1 g |
| 97. | Lorazepam | 0,0175 g | 0,0175 g – 10 g |
| 98. | Lormetazepam | 0,007 g | 0,007 g – 1 g |
| 99. | Mazindol | 0,015 g | 0,015 g – 10 g |
| 100. | Medazepam | 0,15 g | 0,15 g – 10 g |
| 101. | Mefenorex | 0,015 g | 0,015 g – 10 g |
| 102. | Meprobamat | 8,5 g | 8,5 g – 200 g |
| 103. | Mezocarb | 0,175 g | 0,175 g – 2,5 g |
| 104. | Metilfenobarbital | 0,7 g | 0,7 g – 10 g |
| 105. | Metilprilon | 0,15 g | 0,15 g – 10 g |
| 106. | Midazolam | 0,15 g | 0,15 g – 10 g |
| 107. | Nimetazepam | 0,035 g | 0,035 g – 1 g |
| 108. | Nitrazepam | 0,35 g | 0,35 g – 20 g |
| 109. | Nordazepam | 0,105 g | 0,105 g – 1,5 g |
| 110. | (+)–norpseudoefedrină | 1,5 g | 1,5 g – 15 g |
| 111. | Oxazepam | 0,35 g | 0,35 g – 20 g |
| 112. | Oxazolam | 0,35 g | 0,35 g – 20 g |
| 113. | Pemolin | 0,35 g | 0,35 g – 20 g |
| 114. | Pinazepam | 0,105 g | 0,105 g – 1,5 g |
| 115. | Pipradrol | 0,07 g | 0,07 g – 1 g |
| 116. | Prazepam | 0,25 g | 0,25 g – 10 g |
| 117. | Pirovaleron | 0,07 g | 0,07 g – 1 g |
| 118. | Secbutabarbital | 0,7 g | 0,7 g – 10 g |
| 119. | Temazepam | 0,15 g | 0,15 g – 10 g |
| 120. | Tetrazepam | 0,7 g | 0,7 g – 10 g |
| 121. | Tiopental de sodiu | 2,0 g | 2,0 g – 100 g |
| 122. | Tramadol | 0,50 g | 0,50 g – 10 g |
| 123. | Triazolam | 0,00175 g | 0,00175 g – 0,05 g |
| 124. | Vinilbital | 1,5 g | 1,5 g – 15 g |
| 125. | Zopiclon | 0,105 g | 0,105 g – 15 g |
| 126. | Amanita muscaria (L : Fr.) Lam. | 0,3 g | 0,3 g – 1,5 g |
| 127. | Amanita pantherina | 0,3 g | 0,3 g – 1,5 g |
| 128. | Amida acidului lisergic | 0,3 g | 0,3 g – 1,5 g |
| 129. | Benzylpiperazine | 0,3 g | 0,3 g – 1,5 g |
| 130. | CPP (chlorophenylpiperazine) | 0,3 g | 0,3 g – 1,5 g |
| 131. | TFMPP (trifluorometilfenilpiperazina) | 0,3 g | 0,3 g – 1,5 g |
| 132. | DOC (2,5-dimetoxi-4-cloroamfetamina)= 1-(4-clor-2,5-dimetoxifenil) propan-2-amina | 0,3 g | 0,3 g – 1,5 g |
| 133. | DOI (2,5-dimetoxi-4-iodoamfetamina)= 1-(2,5-dimetoxi-4-iodofenil)-propan-2-amina | 0,3 g | 0,3 g – 1,5 g |
| 134. | 7-hidroximitragynina | 0,3 g | 0,3 g – 1,5 g |
| 135. | Ibogaina | 0,3 g | 0,3 g – 1,5 g |
| 136. | Indanilamfetamina | 0,3 g | 0,3 g – 1,5 g |
| 137. | Ketamina | 0,3 g | 0,3 g – 1,5 g |
| 138. | Muscimol | 0,3 g | 0,3 g – 1,5 g |
| 139. | Mitraginina | 0,3 g | 0,3 g – 1,5 g |
| 140. | Mitragyna speciosa Korth (Kratom) | 0,3 g | 0,3 g – 1,5 g |
| 141. | Nitrit de amil | 0,3 g | 0,3 g – 1,5 g |
| 142. | Oripavina | 0,3 g | 0,3 g – 1,5 g |
| 143. | Hallier f. | 0,3 g | 0,3 g – 1,5 g |
| 144. | Salvinorin | 0,3 g | 0,3 g – 1,5 g |
| 145. | 5-APB (Benzo Fury) | 0,1 g | 0,1 – 1,0 g |
| 146. | BDB L (3,4-metilendioxifenil)-2-butanamine | 0,002 g | 0,002 – 1,0 g |
| 147. | Butilone (beta-ceto-MBDB) | 0,002 g | 0,002 – 1,0 g |
| 148. | BZP – N benzylpipertazine | 0,3 g | 0,3 – 1,5 g |
| 149. | MBDB – (RS)-1-(1,3-Benzodioxol-5-yl)-N-methylbutan-2-amine | 0,05 g | 0,05 – 5,0 g |
| 150. | MDE(Cathinone) | 0,002 g | 0,002 – 1,0 g |
| 151. | MDEA (Cathinone) (3,4-methylendioxy-N-ethylamphetamine) | 0,05 g | 0,05 – 5,0 g |
| 152. | AEP Modafinil − 2[(diphenylmethyl)sulfinil] acetamidă (Modiodal, Provigil) | 0,002 g | 0,002 – 1,0 g |
| 153. | APAAN (alfa-fenylacetoacetonitril) | 0,00002 g | 0,00002 – 0,002 g |
| 154. | Amanitamuscaria (Ibotenic acid) ((S)-2-amino-2-(3-hydroxyisoxazol-5-yl) acetic acid) | 0,3 g | 0,3 g – 1,5 g |
| 155. | MBZP (Methylbenzyl piperazine) | 0,3 g | 0,3 g – 1,5 g |
| 156. | Mephedrone (4-methylmethcathinone, 4-MMC) | 0,2 g | 0,2 g – 2,5 g |
| 157. | 4-MMA (4-methyl methamphetamine)-N-methyl-1-(4-methylphenyl) propan-2-amine | 0,002 g | 0,002 g – 1,0 g |
| 158. | PMMA (para methoxy methyl amphetamine) | 0,002 g | 0,002 g – 1,0 g" |
| 159. | Gamma-butyrolactone (GBL) - GBL; butyrolactone; 1,4-lactone; 4-butyrolactone; 4-hydroxybutyric acid lactone; gamma-hydroxybutyric acid lactone şi oxolan-2-one | 10 ml/0,10 g | 10-50 ml/0,10 – 0,50 g |
| 160. | 5-MAPB(5 –APB ME)
C12H15NO, Sinonim:5-(2 Methylaminopropyl) benzofuran |
0,01 g | 0,01 - 0,25 g |
| 161. | 25C-NBOMe (2C-C-NBOMe)
C18H22ClNO3, Sinonim: 2-(4-Chloro-2,5-dimethoxyphenyl)-N-(2 methoxybenzyl) ethanamine |
0,05 g | 0,05 – 0,3 g |
| 162. | 4-Chloromethcathinone (4-CMC)
C10H12ClNO, Sinonim: 1-(4-chlorophenyl)-2-(methylamino) propan-1-one |
0,1 g | 0,1 – 3 g |
| 163. | 4-HO-MET(Metocin)
C13H18N2O, Sinonim: 4-hidroxy – N-methyl-N-ethyltryptamine |
0,1 g | 0,1 – 3 g |
| 164. | 3-MMC
C11H15NO; Sinonim: 3-methyl-N- methylmetcathinone 2-(Methylamino)-1-(3-methylphenyl)-1-propanone |
0,1 g | 0,1 – 1 g |
| 165. | Pentedrone
C12H17NO, Sinonim: α-methylamino-Valerophenone 2-(methylamino)-1-phenyl-1-pentanone, monohydrochloride (±)-1-phenyl-2-(methylamino) pentan-1-one; |
0,03 g | 0,03 – 0,3 g |
| 166. | Pentedrone HCL
C12H17NO·HCI; Sinonim: αmethylamino-Valerophenone 2-(methylamino)-1-phenyl-1-pentanone, monohydrochloride |
0,03 g | 0,03 – 0,3 g |
| 167. | 5F-PB-22
5F-QUPIC C23H21FN2O2; quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate 1-pentyfluoro-1H-indole-3-carboxylic acid 8 – quinolinyl ester |
0,01 g | 0,01 - 0,25 g |
| 168. | XLR-11
5-F-UR-144 5-fluoro UR-144 C21H28FNO;(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone |
0,01 g | 0,01 - 0,25 g |
| 169. | EP
EPH Ethylphenidate C15H21NO2; Sinonim: -ethyl 2-phenyl-2-piperidin-2-ylacetate Ethylphenidate |
0,03 g | 0,03 – 0,3 g |
| 170. | MPA
Methiopropamine C8H13NS; N-Methyl-1-(thiophen-2-yl)propan-2-amine; Methiopropamine 2-Thiopheneethylamine, N,α-dimethyl-(8CI); 1-(Thiophen-2-yl)-2-metylaminopropane |
0,03 g | 0,03 – 3 g |
| 171. | 25B-NBOMe
C18H22BrNO3, Sinonim : 2-(4-bromo – 2,5-dimetoxypenyl)-N-[(2-metoxypenyl)methyl]etanamine |
0,01 g | 0,01 - 0,25 g |
| 172. | Propofol / C12H18O / 2,6-bis(propan-2-yl)phenol sau 2,6-Diisopropylphenol | 0,001 g | 0,001 g - 0,1 g |
| 173. | Scopolamine / C17H21NO4 / 9-Methyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-7-yl 3-hydroxy-2-phenylpropanoate sau Hyoscine | 0,001 g | 0,001 g - 0,1 g |
| 174. | Etizolam (forma de prezentare tabletata) / C17H15ClN4S / 4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | 0,001 g | 0,001 g - 0,1 g |
| 175. | Meclonazepam / C16H12ClN3O3 / (S)-3-methylclonazepam | 0,001 g | 0,001 g - 0,1 g |
| 176. | Fenibut (Phenibut / C10H13NO2 / 4-amino-3-phenyl-butyric acid sau Phenylgamma; PHG) | 0,001 g | 0,001 g - 0,1 g |
| 177. | Tapentadol / C14H23NO / 3-[(2R,3R)-1-(Dimethylamino)-2-methylpentan-3-yl]phenol sau BN-200 | 0,001 g | 0,001 g - 0,1 g |
| 178. | Adrafinil (pulbere) / C15H15NO3S / 2-(Diphenylmethanesulfinyl)-N-hydroxyacetamide | 0,001 g | 0,001 g - 0,1 g |
| 179. | Metizolam (tablete) / C16H13ClN4S / 4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine sau Desmethyletizolam | 0,001 g | 0,001 g - 0,1 g |
| 180. | Benzydamine / C19H23N3O / 3-[(1-Benzyl-1H-indazol-3-yl)oxy]-N,N-dimethylpropan-1-amine | 0,001 g | 0,001 g - 0,1 g |
| 181. | Amyl-nitrite / C5H11NO2 / pentyl nitrite sau 1-nitropentane, Nytramil | 0,001 g | 0,001 g - 0,1 g |
| 182. | Methoxyphenamine/OMMA / C11H17NO / 1-(2-Methoxyphenyl)-N-methylpropan-2-amine sau 2-MMA; MPA; 2-MeO-MA; Orthoxine | 0,001 g | 0,001 g - 0,1 g |
|
|
|||
| 1. | Plantele care nu cresc pe teritoriul Moldovei din cauza condiţiilor climaterice şi care sînt interzise pentru cultivare pe teritoriul Moldovei: | ||
| a) plantă de coca | O plantă | 2 – 5 plante | |
| b) kat | O plantă | 2 – 5 plante | |
| c) Argyreia nervosa | O plantă | 2 - 5 plante | |
| d) Nymphaea caerulea | O plantă | 2 - 5 plante | |
| e) Salvia divinorum | O plantă | 2 - 5 plante | |
| f) Turbina corymbosa | O plantă | 2 - 5 plante | |
| g)Tabernanthe iboga | O plantă | 2 - 5 plante | |
| 2. | Plantele care cresc pe teritoriul Moldovei şi sînt interzise pentru cultivare pe teritoriul Moldovei sau necesită autorizaţie specială: | ||
| a) plantă de mac (indiferent de faza de vegetaţie) | 150 plante | 151 – 500 plante | |
| b) plantă de canabis (cânepă) cu sau fără rădăcină sau părţi ale plantei care conţin tetrahidrocannabinol, indiferent de perioada de vegetaţie | 5 plante | 6 – 50 plante | |
| 3. | Plantele ce conţin precursori şi nu cresc pe teritoriul Moldovei din cauza condiţiilor climaterice şi care sînt interzise pentru cultivare pe teritoriul Moldovei sau necesită autorizaţie specială: | ||
| plantă de efedră | O plantă | 2 – 5 plante | |
|
NOTE: 1. Cultivarea plantelor specificate este periculoasă nu numai din punct de vedere că sînt folosite ca materie primă pentru extragerea substanţelor stupefiante, dar şi ca acţiune ilegală. 2. Cantităţile includ amestecurile substanţelor stupefiante şi/sau psihotrope cu precursori, adaosuri (preparate medicamentoase, acizi, glucoză, crohmal, făină etc.), aflîndu-se în orice stare de agregare. 3. Cantităţile mici, mari sau deosebit de mari de izomeri, stereoizomeri, eteri, esteri, analogi, metaboliţi, săruri (inclusiv sărurile izomerilor, stereoizomerilor, esterilor, analogilor şi metaboliţilor) ale substanţelor stupefiante sau psihotrope şi plante sau părţi ale acestora care conţin orice agent inclus în tabel corespund cantităţilor calculate de substanţe stupefiante sau psihotrope enumerate. 4. Cantităţile mari de substanţe stupefiante, psihotrope şi precursori, care au fost depistate în circulaţie ilegală, se consideră cantităţile ce depăşesc cantităţile mici pînă la cantităţile maxime indicate în tabela cantităţilor mari. 5. Cantităţile deosebit de mari de substanţe stupefiante, psihotrope şi precursori, care au fost depistate în circulaţie ilegală, se consideră cantităţile ce depăşesc cantităţile mari. |
|||
[Lista modificată prin Hot.Guv. nr.223 din 26.03.2024, în vigoare 29.03.2024]
[Lista completată prin Hot.Guv. nr.620 din 02.08.2017, în vigoare 04.08.2017]
[Lista completată prin Hot.Guv. nr.1004 din 24.08.2016, în vigoare 02.09.2016]
[Lista completată prin Hot.Guv. nr.466 din 15.04.2016, în vigoare 22.04.2016]
[Lista completată prin Hot.Guv. nr.430 din 09.06.2014, în vigoare 13.06.2014]
[Lista completată prin Hot.Guv. nr.20 din 18.01.2014, în vigoare 24.01.2014]
[Lista modificată prin Hot.Guv. nr.825 din 09.11.2011, în vigoare 18.11.2011]
[Lista modificată prin Hot.Guv. nr.853 din 21.09.2010, în vigoare 28.09.2010]
[Lista în redacţia Hot.Guv. nr.43 din 26.01.2009, în vigoare 03.02.2009]